Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3044491	non-hdl	— (—)	27804	38398	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any death

8973

0.06

249.81

1.2

1.5

—

Diabetes, insulin treatment (Kela reimbursement)

1600

21690

0.43

237.30

1.6

1.4

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1562

21072

0.43

230.62

1.6

1.4

—

Insulin medication

444

14795

0.24

219.06

1.4

—

Type 2 diabetes, wide definition

864

15439

0.35

216.14

1.6

1.4

—

Heart failure, not strict

593

12628

0.31

188.23

1.5

—

Insulin, combination of fast acting with intermediate-acting or long-acting

444

14740

0.27

188.21

1.4

—

Diabetes medication

2100

23468

0.52

185.67

1.6

1.4

—

Substance abuse, excluding more controls

796

17489

0.37

170.91

1.4

—

Diabetes mellitus

2214

23365

0.54

168.87

1.6

1.4

—

Diabetes, varying definitions

2207

23266

0.54

165.95

1.6

1.4

—

Insulin, intermediate and long-acting

398

13559

0.28

158.84

1.4

—

Mental and behavioural disorders due to psychoactive substance use

840

18516

0.41

149.06

1.4

—

Schizophrenia or delusion, excluding more controls

298

11586

0.24

148.74

1.4

—

Substance abuse

796

18156

0.40

148.54

1.4

—

Type 2 diabetes

2121

21734

0.55

145.63

1.6

1.4

—

Kela-code for severe mental illness

363

12517

0.28

143.04

1.4

—

Unspecified mental disorder

484

14282

0.32

141.08

1.4

—

Other bacterial diseases

1697

20920

0.53

137.74

1.4

—

Other (not insulin) diabetes medications

1991

20646

0.56

134.91

1.6

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1417

19163

0.51

133.59

1.5

1.4

—

Schizophrenia or delusion

298

10955

0.26

132.14

1.4

—

795

16641

0.42

131.61

1.4

—

883

17305

0.43

131.52

1.4

—

Schizophrenia, schizotypal and delusional disorders

300

10958

0.26

131.49

1.4

—

Biguanides

1869

19968

0.56

128.16

1.6

1.4

—

Mental and behavioural disorders due to alcohol

678

15864

0.40

127.61

1.4

—

Implicit Sepsis

956

15513

0.45

127.58

1.5

1.4

—

Alcohol use disorder, Swedish definition

736

15729

0.41

123.97

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1750

21186

0.56

122.14

1.5

1.4

—

Any mental disorder

2784

21960

0.62

120.90

1.4

—

Implicit Sepsis

1299

18014

0.51

118.75

1.5

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1937

22673

0.58

118.58

1.4

—

Pneumonia, organism unspecified

1843

22173

0.57

118.31

1.4

—

Renal tubulo-interstitial diseases

1437

19654

0.53

117.93

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2137

24076

0.59

117.63

1.4

—

Type 2 diabetes, strict (exclude DM1)

2076

20249

0.59

115.36

1.6

1.4

—

Insulin, fast-acting

275

9835

0.27

114.88

1.4

—

Type 2 diabetes, definitions combined

2077

20231

0.59

114.82

1.6

1.4

—

Other bacterial diseases

2202

22818

0.60

114.65

1.4

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

523

13489

0.37

114.27

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

2263

24586

0.60

114.13

1.4

—

Insulin, fast-acting or short human

276

9806

0.27

113.76

1.4

—

All pneumoniae

2289

24651

0.61

113.32

1.4

—

Persons encountering health services for specific procedures and health care

2606

24375

0.63

110.31

1.4

—

Alcohol use disorder, ICD-based

485

12527

0.37

105.27

1.4

—

All kidney diseases

2165

23623

0.61

102.96

1.4

—

Bleeding

1225

16121

0.53

102.55

1.4

—

Type 2 diabetes, definitions combined, including avohilmo

2200

20393

0.61

101.93

1.6

1.4

—

Influenza and pneumonia

2564

24967

0.64

100.22

1.4

—

Metabolic disorders

2050

20126

0.61

99.83

1.5

1.4

—

Oxycodone

207

7311

0.25

99.33

1.4

1.5

—

Type 1 diabetes

236

8380

0.27

98.53

1.3

1.4

—

Benzodiazepine use

2285

24554

0.63

98.18

1.5

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

422

9049

0.36

96.93

1.5

—

Heart failure,strict

253

6180

0.28

96.52

1.4

1.5

—

Sub-endpoint used in defining T1D endpoints

233

8162

0.27

96.52

1.3

1.4

—

Mood disorders, excluding more controls

2381

21931

0.63

96.07

1.4

—

Schizophrenia

5361

0.12

95.77

1.6

1.4

—

Heart failure, strict

255

6129

0.29

94.19

1.4

1.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2097

22490

0.62

93.31

1.5

1.4

—

All-cause Heart Failure

248

5972

0.29

91.78

1.5

—

Type 1 diabetes, wide definition

203

7515

0.26

91.56

1.3

1.4

—

Periodontitis

2072

21725

0.62

90.80

1.4

—

Personality disorders, excluding more controls

444

11037

0.38

90.28

1.3

1.4

—

Chronic periodontitis, including avohilmo

2068

21685

0.63

89.78

1.4

—

Type 1 diabetes, wide definition, subgroup 1

197

7311

0.26

89.51

1.4

—

Polyarthropathies

1411

15736

0.57

88.46

1.4

—

Other and unspecified nonorganic psychotic disorders

204

7330

0.26

88.00

1.4

—

Autoimmune diseases excluding thyroid diseases

2742

22095

0.66

87.69

1.4

—

Alcohol dependence

197

7265

0.26

87.21

1.4

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

2686

21775

0.66

87.07

1.4

—

Tramadol

1824

17837

0.61

85.00

1.5

1.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2095

19466

0.64

82.29

1.4

—

2095

19466

0.64

82.29

1.4

—

Heart failure and antihypertensive medication

188

4482

0.26

80.18

1.5

1.4

—

Disorders of adult personality and behaviour

480

11026

0.42

79.91

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2312

22346

0.66

77.46

1.4

—

Mood disorders

2648

24692

0.68

75.77

1.4

—

Personality disorders

444

10293

0.41

75.71

1.3

1.4

—

Hypertension, essential

2076

17745

0.65

75.53

1.5

1.4

—

STROKE

978

11955

0.54

74.77

1.5

1.4

—

Cerebrovascular diseases

866

11373

0.52

74.72

1.5

—

Mood [affective] disorders

2650

24684

0.68

74.71

1.4

—

Hypertensive diseases

2173

18310

0.65

74.55

1.5

1.4

—

Hypertension

2172

18296

0.65

74.47

1.5

1.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

562

11763

0.46

73.81

1.3

—

All chronic kidney diseases

577

9983

0.46

73.80

1.4

—

Disorders of lipoprotein metabolism and other lipidaemias

1584

15603

0.62

73.35

1.6

1.4

—

Depression

2523

24586

0.68

71.84

1.3

1.4

—

Substance use, excluding alcohol

230

6946

0.32

71.16

1.4

—

Other chronic obstructive pulmonary disease, including avohilmo

361

7381

0.40

68.98

1.4

1.5

—

Renal failure

231

6139

0.33

67.79

1.5

—

Bacterial Sepsis

357

7496

0.40

67.37

1.4

1.5

—

Implicit bacterial Sepsis

301

6861

0.37

67.08

1.4

1.5

—

Poisoning by drugs, medicaments and biological substances

347

8444

0.39

66.61

1.3

1.4

—

Stroke, including SAH

593

8731

0.48

66.46

1.5

—

Cerebrovascular diseases (FINNGEN)

623

8686

0.49

65.83

1.5

1.4

—

ILD medications: immunosuppressive drugs

1425

20841

0.62

65.77

1.4

—

Suicide or other Intentional self-harm

347

8385

0.40

65.40

1.3

1.4

—

Erysipelas

1329

16285

0.61

65.28

1.4

—

Major coronary heart disease event excluding revascularizations

640

8381

0.50

64.82

1.6

1.5

—

Organic, including symptomatic, mental disorders

194

4461

0.30

64.81

1.4

1.5

—

Disorders of lens

977

10561

0.57

63.99

1.5

—

Spondylopathies

1696

15400

0.65

63.43

1.5

1.4

—

Dyspnoea

1895

20704

0.66

62.84

1.5

1.4

—

Specific personality disorders

386

8780

0.42

62.82

1.3

—

Pure hypercholesterolaemia

1271

13364

0.61

62.50

1.6

1.5

—

Poisoning by medicine

305

7616

0.38

62.38

1.3

1.4

—

COPD

249

5672

0.35

62.24

1.4

1.5

—

Anaemias

670

8234

0.51

61.97

1.4

1.3

—

Diseases of arteries, arterioles and capillaries

704

9766

0.52

61.94

1.5

—

Any reimbursement code in KELA

2407

17072

0.69

61.77

1.4

1.3

—

Hypertensive diseases (excluding secondary)

1699

14820

0.65

61.23

1.5

1.4

—

Implicit bacterial Sepsis

251

6098

0.36

60.90

1.5

—

Chronic periodontitis, complicated

747

13472

0.54

60.81

1.4

1.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

4374

22115

1.33

60.39

1.4

—

Heart failure and coronary heart disease

164

3944

0.29

60.38

1.5

—

Hard cardiovascular diseases

1822

16047

0.66

59.13

1.6

1.4

—

Asthma, unspecified (mode), excluding more controls

1181

14201

0.61

58.87

1.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

562

10959

0.49

58.84

1.3

—

Dental caries

376

8131

0.43

58.80

1.4

—

Insulin, fast-acting (human)

125

4713

0.25

58.56

1.3

1.4

—

Other chronic obstructive pulmonary disease

233

5345

0.35

58.16

1.4

1.5

—

Chronic apical periodontitis

3102

23786

0.73

57.65

1.4

—

Acute alcohol intoxication

275

6978

0.38

57.54

1.4

—

Anxiety (asthma-related co-morbidities)

1873

21010

0.67

57.50

1.3

1.4

—

Asthma, unspecified (mode)

1181

14220

0.61

57.46

1.4

—

Stroke, excluding SAH

523

7684

0.49

57.17

1.5

—

Bacterial infection, other or unspecified

721

11034

0.54

56.71

1.4

—

Heart failure and bmi 25plus

152

3495

0.29

56.44

1.5

—

Peripheral artery disease

167

4299

0.30

56.27

1.5

—

Disorders of choroid and retina

1316

14575

0.63

56.07

1.5

1.4

—

Care involving use of rehabilitation procedures

1302

18552

0.63

55.59

1.4

—

COPD, early/later onset

233

5340

0.36

55.32

1.4

1.5

—

COPD (mode)

173

4260

0.31

55.30

1.3

1.5

—

Psychiatric diseases

2897

19651

0.73

55.18

1.4

—

Malaise and fatigue

789

11112

0.56

55.00

1.4

—

Disorders of gallbladder, biliary tract and pancreas

2263

19985

0.70

54.61

1.4

—

COPD, hospital admissions

233

5296

0.37

53.97

1.4

1.5

—

Bacterial infection, other or unspecified

605

9853

0.52

53.91

1.5

1.4

—

Other retinal disorders

734

10176

0.55

53.89

1.5

1.4

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

222

5948

0.36

53.75

1.2

1.4

—

Ischemic heart diseases

1723

15149

0.67

53.34

1.6

1.4

—

Autoimmune diseases

3307

22223

0.75

53.03

1.4

—

Caries of dentine

315

7073

0.42

52.75

1.4

—

Oral corticosteroids

2859

22800

0.73

52.73

1.4

—

COPD related to multimorbidity

141

4050

0.29

52.50

1.4

1.5

—

Complications of surgical and medical care, not elsewhere classified

2405

22659

0.72

52.48

1.4

—

General symptoms and signs

3349

22088

0.75

52.24

1.4

—

Major coronary heart disease event

1630

14495

0.67

52.11

1.6

1.5

—

Ischaemic heart disease, wide definition

1291

12334

0.64

51.95

1.6

1.5

—

Other anxiety disorders

1295

17077

0.64

51.52

1.3

—

Fever of other and unknown origin

1143

15945

0.63

51.36

1.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

364

5484

0.44

51.19

1.5

1.4

—

Nerve, nerve root and plexus disorders

2739

22448

0.74

49.15

1.4

—

Septicaemia

373

7370

0.46

47.91

1.4

—

All anxiety disorders

1912

21131

0.70

47.75

1.3

1.4

—

Myocardial infarction

490

6667

0.51

47.58

1.6

1.5

—

Bipolar affective disorders

329

7124

0.44

47.22

1.3

—

Senile cataract

765

7996

0.58

47.17

1.6

1.5

—

Acute alcohol intoxication, ICD10

243

5945

0.39

47.16

1.4

—

Anxiety disorders, excluding more controls

2482

21731

0.73

47.13

1.4

—

ILD medications

3336

23399

0.76

46.05

1.4

—

Explicit Sepsis

470

8442

0.51

45.69

1.4

—

First line medication for Crohn's disease

3314

23148

0.76

45.41

1.4

—

Non-ischemic cardiomyopathy

141

3565

0.31

45.32

1.3

1.5

—

Alcohol abuse, main dg, excluding more controls

186

4985

0.36

44.95

1.4

—

Ischaemic Stroke, excluding all haemorrhages

482

6842

0.52

44.67

1.5

—

Diseases of pulp and periapical tissues, including avohilmo

3061

20662

0.76

44.49

1.4

—

Inflammatory bowel disease treatment related agents

3310

23856

0.77

44.44

1.4

—

Erysipelas

859

12309

0.61

44.41

1.4

—

Other medical care

503

8452

0.53

44.39

1.3

1.4

—

Intracranial trauma

1685

16762

0.69

44.31

1.4

—

Coronary atherosclerosis

943

9512

0.62

44.25

1.7

1.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

101

3673

0.26

44.17

1.4

1.5

—

Dialysis, with operation codes

2447

0.11

44.02

1.3

1.5

—

Other disorders of fluid, electrolyte and acid-base balance

205

5042

0.38

43.98

1.5

—

Constipation

1824

17650

0.70

43.95

1.5

1.4

—

Other heart diseases

1579

14702

0.68

43.78

1.5

1.4

—

Other septicaemia

306

6444

0.45

43.52

1.4

—

COPD, hospital admission 2, with asthma infections

122

3467

0.30

43.49

1.3

1.5

—

Diseases of oesophagus, stomach and duodenum

2887

22552

0.75

43.47

1.5

1.4

—

Coronary revascularization (ANGIO or CABG)

1596

13961

0.69

43.32

1.6

1.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

3177

22914

0.76

42.94

1.4

—

Percutaneous Coronary Intervention

1596

13945

0.69

42.76

1.6

1.5

—

General examination and investigation of persons without complaint and reported diagnosis

1887

13658

0.71

42.40

1.4

—

Non-selective monoamine reuptake inhibitors

524

9157

0.54

42.26

1.5

1.4

—

Emergency coronary revascularization (for ACS)

1642

14143

0.70

42.26

1.6

1.5

—

Atherosclerosis, excluding cerebral and coronary sclerosis

153

3539

0.34

42.17

1.5

—

Persons encountering health services in other circumstances, wide

3426

22491

0.77

41.78

1.4

—

Chronic kidney disease

118

3811

0.30

41.77

1.6

1.5

—

Dizziness and giddiness

1524

17202

0.69

41.54

1.5

1.4

—

Finngen Rheumatological endpoints

2967

21835

0.76

41.45

1.4

—

Pain in limb

2153

19418

0.73

41.31

1.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

2614

0.17

41.25

1.3

—

Myocardial infarction, strict

454

6098

0.52

40.75

1.6

1.5

—

Angina pectoris

681

7663

0.58

40.74

1.6

1.5

—

Other neurological diseases

1121

13250

0.66

40.71

1.5

1.4

—

Type 1 diabetes, strict (exclude DM2)

114

3659

0.29

40.66

1.2

1.3

—

Type 1 diabetes, definitions combined

117

3697

0.30

40.50

1.2

1.3

—

Sulfonylureas

111

2938

0.30

39.58

1.5

—

Nephropathy related operations

2336

0.14

39.53

1.3

1.5

—

Other degenerative diseases of the nervous system

261

4371

0.44

39.29

1.4

—

Acute tubulo-interstitial nephritis

1046

13633

0.65

39.23

1.4

—

Lower back pain or/and sciatica

2890

24288

0.77

39.22

1.4

—

Acute and transient psychotic disorders

117

3656

0.30

39.08

1.4

—

Diabetic maculopathy, excluding more controls

2557

0.19

38.05

1.4

—

Malignant neoplasm of digestive organs

281

4766

0.46

37.57

1.4

1.5

—

Other soft tissue disorders, not elsewhere classified

2672

20269

0.76

37.54

1.4

—

Used for control exclusion in common control thyroid runs

3338

21296

0.78

37.53

1.4

—

Aplastic and other anaemias

378

6825

0.51

37.46

1.5

1.4

—

Spondylosis

974

12048

0.65

37.43

1.5

—

Low back pain

2074

19866

0.74

37.41

1.4

—

Second line medication for Crohn's disease

1227

17722

0.68

37.28

1.4

—

Type 1 diabetes, strict definition

3207

0.28

37.24

1.2

1.3

—

Use of hypnotics and sedatives

2962

21713

0.77

37.19

1.5

1.4

—

Dorsalgia

3009

20545

0.77

36.96

1.4

—

Other disorders of ear

2134

18566

0.74

36.78

1.5

1.4

—

Valvular heart disease excluding rheumatic fever

595

7295

0.58

36.78

1.5

—

Other antidepressants

3043

19843

0.78

36.67

1.4

—

Hypertensive heart and/or renal disease

136

2921

0.34

36.58

1.4

1.5

—

L04AA Selective immunosuppressants

306

6216

0.48

36.23

1.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2403

0.23

36.22

1.4

1.5

—

L04AX Other immunosuppressants

1172

16962

0.68

36.02

1.4

—

Postmenopausal atrophic vaginitis

877

3023

1.64

35.94

1.5

1.4

—

Non-rheumatic valve diseases

593

7218

0.58

35.74

1.5

—

Atrial fibrillation and flutter with reimbursement

446

5151

0.54

35.67

1.5

—

Alcohol abuse, main dg

186

4514

0.40

35.64

1.4

—

Emotionally unstable personality disorder

199

4661

0.41

35.49

1.2

1.3

—

Type 1 diabetes, strict definition, subgroup 1

3058

0.28

35.39

1.2

1.3

—

Presence of other functional implants

652

7439

0.60

35.14

1.5

—

Early onset COPD, excluding more controls

197

4659

0.41

34.93

1.3

1.5

—

Malignant neoplasm

2316

17877

0.76

34.79

1.5

1.4

—

Problems related to lifestyle

114

3398

0.32

34.71

1.3

1.4

—

Convulsions, not elsewhere classified

405

7341

0.53

34.67

1.4

—

Bacterial pneumoniae

566

8409

0.58

34.59

1.4

—

Bacterial pneumonia, not elsewhere classified

510

7741

0.57

34.01

1.4

—

Symptoms and signs involving the urinary system

1452

15348

0.71

33.81

1.5

1.4

—

Atrial fibrillation and flutter

790

7945

0.63

33.80

1.5

1.4

—

COPD, hospital admissions 1, only main diagnosis

163

3561

0.39

33.76

1.4

1.5

—

Missing teeth due to accident, extraction or parodontitis

855

12258

0.65

33.56

1.4

1.5

—

Sciatica+with lumbago

1189

15598

0.69

33.51

1.4

—

Epilepsy

478

8269

0.56

33.18

1.4

—

Asthma/COPD (KELA code 203)

2738

23802

0.78

33.17

1.4

—

Anxiety disorders

2734

24130

0.78

33.09

1.4

—

Non-invasive ventilation

541

8072

0.58

32.87

1.5

1.4

—

Neurotic, stress-related and somatoform disorders

2722

24085

0.78

32.57

1.4

—

Other anaemias

347

6274

0.52

32.55

1.5

—

Other and unspecified anaemias

342

6225

0.52

32.51

1.5

—

Endocrine, nutritional and metabolic diseases

3016

19168

0.79

32.51

1.4

1.3

—

Schizoaffective disorder

2375

0.23

32.17

1.4

—

Other menopausal disorders

1049

3962

1.53

31.92

1.5

1.4

—

Solid cancers, helper endpoint

2308

17538

0.77

31.23

1.5

1.4

—

Injuries to the head

3204

24392

0.80

31.06

1.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

1052

15117

0.68

30.97

1.4

—

Transplanted organ and tissue status

2308

0.23

30.96

1.4

—

Other heart diseases, wide

2903

22192

0.79

30.91

1.5

1.4

—

Glucagon-like peptide-1 (GLP-1) analogues

505

8437

0.58

30.68

1.6

1.5

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

505

8437

0.58

30.68

1.6

1.5

—

Other symptoms and signs involving cognitive functions and awareness

541

8138

0.60

30.50

1.5

1.4

—

Diabetic retinopathy, excluding more controls

162

2237

0.40

30.50

1.4

1.6

—

Other cataract

504

6428

0.58

30.38

1.5

—

Gonarthrosis [arthrosis of knee](FG)

1816

13982

0.74

30.33

1.5

—

Any dementia, excluding more controls

1915

0.29

30.26

1.3

1.5

—

Nutritional anaemias

624

9575

0.62

30.17

1.4

—

Chronic diseases of tonsils and adenoids

3610

18612

1.24

30.16

1.4

—

Obesity due to excess calories

1105

15635

0.69

30.12

1.4

—

Other reaction to severe stress, and adjustment disorders

1042

14861

0.68

30.09

1.3

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3367

22489

0.80

29.93

1.4

—

Caries of dentine, including avohilmo

2241

14747

0.77

29.87

1.4

—

Early onset COPD

197

4383

0.44

29.82

1.3

1.5

—

Other diseases of pleura

376

5958

0.55

29.61

1.5

—

Dementia, including avohilmo

140

2495

0.38

29.61

1.4

1.5

—

Spinal stenosis

667

7938

0.63

29.59

1.6

1.5

—

Persons encountering health services in other circumstances

866

12703

0.67

29.54

1.3

1.4

—

Depression medications

1403

9630

0.71

29.52

1.4

1.3

—

Presence of cardiac and vascular implants and grafts

373

5034

0.54

29.51

1.6

1.5

—

Gonarthrosis,primary

1778

14484

0.75

29.46

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

2626

18965

0.78

29.41

1.4

1.3

—

Hypertensive Heart Disease

122

2599

0.36

29.25

1.4

1.5

—

Bacterial pneumonia (organism specified)

595

8624

0.62

29.24

1.4

—

Care involving dialysis

1543

0.09

29.20

1.0

1.5

—

Diabetic nephropathy, excluding more controls

1662

0.20

29.01

1.6

—

Concussion

1498

16411

0.73

28.88

1.4

—

Cholelithiasis, broad definition with cholecystitis

1973

17233

0.76

28.76

1.4

—

L04AD Calcineurin inhibitors

2798

0.32

28.50

1.3

1.4

—

Dementia

118

2232

0.36

28.48

1.4

1.5

—

Insomnia

3769

22674

1.23

28.47

1.4

—

Reimbursement for rheumatic diseases

1139

15841

0.71

28.47

1.4

—

Periapical abscess

986

14082

0.69

28.35

1.4

—

Conductive and sensorineural hearing loss

1494

13570

0.73

28.31

1.5

—

Rheumatoid arthritis

478

7146

0.59

28.24

1.4

—

Malignant neoplasm, wide definition for exclusion

2547

18765

0.79

28.21

1.5

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1582

13266

0.74

28.01

1.4

—

Diseases of pulp and periapical tissues and dental caries

1833

12290

0.75

27.73

1.4

—

Asthma, excluding more controls

2475

16248

0.78

27.55

1.4

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2754

0.33

27.49

1.5

—

Autoimmune diseases related-to ILD

2283

24668

0.78

27.49

1.4

—

Chronic lower respiratory diseases

3712

23863

0.82

27.45

1.4

—

Mixed and other personality disorders

2768

0.33

27.44

1.3

1.4

—

Any event in cancer register

2740

20042

0.79

27.40

1.4

—

Dental caries, including avohilmo

2064

13585

0.77

27.35

1.4

—

Type1 diabetes, definitions combined, early onset

2428

0.29

27.27

1.2

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

2043

0.24

27.02

1.2

1.4

—

Sleep disorders

3774

22681

1.22

26.43

1.4

—

Infections, IBD-co-morbidities

341

4350

0.54

26.39

1.4

—

Glomerular disorders in diseases classified elsewhere

2217

0.27

26.33

1.4

—

Acute renal failure

112

2997

0.37

26.31

1.5

—

Asthma

2495

16366

0.79

26.30

1.4

—

Any dementia

1814

0.32

26.24

1.3

1.5

—

Selective serotonin reuptake inhibitors

3114

19860

0.81

26.00

1.4

—

Other specified and unspecified personality disorders

113

2927

0.37

25.74

1.4

—

Fentanyl

1423

0.11

25.68

1.4

1.5

—

Asthma (diagnoses ohter than nonallergic)

2269

23611

0.79

25.65

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2543

0.33

25.59

1.3

1.5

—

Obesity

1664

20849

0.76

25.57

1.4

—

Syncope and collapse

774

9745

0.67

25.56

1.5

1.4

—

Sensorineural hearing loss

1316

12066

0.73

25.55

1.5

—

Iron deficiency anaemia

553

8567

0.63

25.49

1.4

—

Diverticular disease of intestine

1419

12100

0.74

25.43

1.5

—

Obesity and other hyperalimentation

1675

20889

0.76

25.11

1.4

—

Osteopathies and chondropathies

1022

13264

0.71

25.08

1.4

—

Diabetic retinopathy

183

2479

0.45

25.06

1.4

1.6

—

Other symptoms and signs involving the nervous and musculoskeletal systems

785

11423

0.68

25.00

1.4

—

Carpal tunnel syndrome

1372

16099

0.74

24.99

1.4

—

Coxarthrosis [arthrosis of hip](FG)

909

9126

0.69

24.95

1.5

—

Coxarthrosis

880

8344

0.69

24.95

1.5

—

Parasetamol

2845

17686

0.80

24.91

1.4

—

COPD/asthma related infections

3204

19469

0.82

24.87

1.4

—

COPD/asthma/ILD related infections

3204

19469

0.82

24.87

1.4

—

Sequelae of cerebrovascular disease

253

4211

0.51

24.85

1.5

—

Complications of procedures, not elsewhere classified

2039

21332

0.78

24.70

1.4

—

Use of disulfiram, acamprosate or naltrexone

105

2746

0.36

24.52

1.5

1.4

—

1243

0.08

24.27

1.5

—

Alcoholic liver disease

1857

0.24

24.17

1.3

1.5

—

Necrosis of pulp, including avohilmo

1650

21215

0.76

24.16

1.4

—

Pain, not elsewhere classified

557

8603

0.63

24.13

1.4

—

Intestinal infectious diseases

4516

21923

1.19

23.75

1.4

—

Hypo-osmolality and hyponatraemia

2538

0.35

23.50

1.4

1.5

—

Diseases of liver

529

8228

0.63

23.49

1.4

—

Focal epilepsy

262

4867

0.53

23.45

1.4

—

Cholelithiasis

1928

16846

0.78

23.39

1.4

—

Asthma (only as main-diagnosis), excluding more controls

2283

16248

0.79

23.37

1.4

—

Cutaneous abscess, furuncle and carbuncle

501

7854

0.62

23.35

1.4

—

Kidney transplant status

1216

0.09

23.35

1.1

1.4

—

Nausea and vomiting

384

6291

0.59

23.20

1.3

1.4

—

Gout

202

3601

0.49

23.20

1.6

1.5

—

Viral hepatitis, IBD co-morbidity

2424

0.35

23.12

1.4

1.3

—

Examination and observation for other reasons

1842

13569

0.77

23.01

1.4

—

Liquid cancers, helper endpoint

433

6142

0.61

23.00

1.5

—

Implicit viral Sepsis

336

5784

0.57

22.72

1.4

—

Asthma (mode)

2493

16431

0.80

22.71

1.4

—

Infections of the skin and subcutaneous tissue

1498

19218

0.76

22.65

1.4

—

Preparatory care for dialysis

730

0.08

22.47

1.0

1.5

—

Glomerular diseases

178

3690

0.47

22.38

1.5

1.4

—

Use of biperiden

1192

0.10

22.31

1.5

1.4

—

Implicit viral Sepsis

182

3746

0.48

22.26

1.5

1.4

—

Viral Sepsis

183

3757

0.48

22.22

1.4

—

Mental and behavioural disorders due to opioids

1365

0.17

21.97

1.2

1.3

—

Oedema, not elsewhere classified

473

7325

0.63

21.86

1.4

—

Unstable angina pectoris

289

4062

0.55

21.66

1.6

1.5

—

Other acute lower respiratory infections

1090

13986

0.73

21.61

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

3810

22899

1.19

21.60

1.4

—

Alcohol withdrawal state with delirium

1463

0.20

21.58

1.6

1.5

—

Asthma (only as main-diagnosis)

2294

16366

0.80

21.46

1.4

—

Other and unspecified iron deficiency

423

6776

0.61

21.41

1.4

—

Other nutritional deficiencies

1803

21355

0.78

21.41

1.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1431

0.20

21.28

1.3

1.5

—

Persistent delusional disorders

1659

0.25

21.16

1.4

—

Cardiac arrhythmias

2200

17617

0.80

21.10

1.4

—

Diseases of the digestive system

636

9289

0.67

21.04

1.4

—

Hyperlipidaemia, other/unspecified

414

6128

0.61

21.03

1.6

1.5

—

Fall on same level

3693

23760

0.84

20.98

1.4

—

Gonarthrosis

1609

11727

0.77

20.81

1.5

1.4

—

Focal epilepsy, strict definition

235

4339

0.53

20.66

1.5

1.4

—

Degenerative diseases of the nervous system

1701

0.36

20.64

1.4

1.5

—

Cystitis

3076

15229

1.21

20.61

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

577

7598

0.66

20.60

1.3

—

Female infertility, cervical, vaginal, other or unspecified origin

1254

6153

1.35

20.32

1.3

—

Extracorporeal dialysis

1054

0.09

20.23

1.0

1.4

—

Rotator cuff syndrome

1424

13170

0.77

20.13

1.5

1.4

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

228

4211

0.53

20.11

1.4

—

Opioids

3385

20803

0.84

20.11

1.4

—

Other intervertebral disc disorders

2480

18134

0.81

20.10

1.5

1.4

—

Phobic anxiety disorders

315

5278

0.58

20.09

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

726

10126

0.69

19.96

1.3

—

Triptan medication for migraine, single purchase ok

3500

20092

1.19

19.94

1.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

3500

20092

1.19

19.94

1.4

—

Persistent mood disorders

329

5473

0.59

19.85

1.4

—

Mental retardation, excluding more controls

1008

0.10

19.79

1.1

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2572

19896

0.82

19.78

1.4

—

Shoulder lesions

2055

15382

0.80

19.75

1.5

1.4

—

Asthma-related infections

1337

16892

0.77

19.54

1.4

—

Asthma, hospital admission 2, infections

1337

16892

0.77

19.54

1.4

—

Intracranial injury

1297

15893

0.76

19.50

1.4

—

Lung cancer and mesothelioma

2052

0.39

19.49

1.4

1.5

—

ILD medications: azathioprine

257

4528

0.55

19.48

1.3

1.4

—

Retention of urine

305

4265

0.58

19.48

1.5

—

Complications of medical and surgical care

1681

19396

0.79

19.39

1.4

—

Other ill-defined and unspecified causes of mortality

731

0.12

19.26

1.3

1.5

—

Rheumatism, unspecified

158

3216

0.48

19.06

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2314

18518

1.23

19.03

1.4

1.3

—

Status post-ami

143

2323

0.46

18.92

1.6

1.5

—

Diabetic retinopathy, strict definition

1902

0.37

18.65

1.3

1.6

—

Chronic viral hepatitis

1835

0.33

18.59

1.3

1.4

—

Azathioprine

257

4468

0.56

18.56

1.3

1.4

—

Diabetic nephropathy

1522

0.27

18.55

1.5

1.6

—

Coxibs

999

3858

1.38

18.38

1.4

1.3

—

Ulcer of lower limb, not elsewhere classified

1909

0.34

18.28

1.6

1.5

—

Pain in throat and chest

2739

19613

0.83

18.24

1.5

1.4

—

Dermatitis

1372

17414

0.78

18.14

1.4

—

Asthma-related pneumonia

489

7307

0.66

18.06

1.4

—

Mild mental retardation

613

0.09

17.98

1.2

1.4

—

Dental operations

1720

11029

0.79

17.83

1.4

—

Mental retardation, wide definition

969

0.12

17.82

1.3

—

Unspecific neurodegenerative disorder

110

1734

0.43

17.74

1.4

1.5

—

Other/unspecified dorsalgia

821

11071

0.72

17.70

1.4

—

Asthma, hospital admissions 3, pneumonia

493

7323

0.66

17.68

1.4

—

Asthma-related pneumonia or sepsis

493

7323

0.66

17.68

1.4

—

Other dorsopathies, not elsewhere classified

3365

20616

0.85

17.62

1.4

—

Secondary hypertension

1933

0.37

17.57

1.5

1.4

—

Mental and behavioural disorders due to cannabinoids

1178

0.20

17.43

1.1

1.3

—

Allergic conjunctivitis

2369

19215

1.22

17.41

1.4

—

Amputation

1081

0.16

17.27

1.4

1.5

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1845

0.35

17.26

1.4

1.3

—

Mental retardation

925

0.11

17.26

1.1

1.3

—

Female infertility

1330

6283

1.31

17.08

1.3

—

Persons encountering health services in circumstances related to reproduction

2685

15202

1.21

17.05

1.4

—

Gastroduodenal ulcer

195

3596

0.53

17.03

1.4

1.5

—

Other disorders of skin and subcutaneous tissue

1378

15489

0.78

17.00

1.4

—

Lyme disease

932

6972

1.36

16.92

1.5

1.4

—

Abnormalities of breathing

2988

20419

0.84

16.92

1.5

1.4

—

Nonorganic sleeping disorders, excluding more controls

489

7175

0.67

16.87

1.4

1.3

—

Other viral hepatitis

2142

0.40

16.85

1.3

1.4

—

Other arrhythmias

1704

15878

0.80

16.85

1.5

1.4

—

Venous thromboembolism

815

10661

0.73

16.83

1.4

—

Depression or dysthymia

2027

13625

0.81

16.82

1.4

—

Other spirochaetal diseases

940

7048

1.36

16.80

1.5

1.4

—

Malignant neoplasm of bronchus and lung, including Hilmo

1871

0.41

16.76

1.4

1.5

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

1094

0.19

16.69

1.2

1.3

—

Seropositive rheumatoid arthritis

332

5276

0.62

16.66

1.4

—

Diabetic maculopathy

1449

0.30

16.65

1.4

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

1876

0.42

16.59

1.4

1.5

—

Gout, FINNGEN

202

3659

0.54

16.58

1.6

1.5

—

Hypothyroidism (congenital or acquired)

1241

8952

0.77

16.58

1.4

1.3

—

Assault

317

5060

0.61

16.56

1.3

1.4

—

Fibromyalgia

156

3019

0.50

16.56

1.3

1.4

—

Peripheral artery operations in Hilmo

1315

0.25

16.50

1.5

—

Arthrosis

2104

13980

0.82

16.44

1.5

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2239

13658

0.82

16.42

1.4

—

Rheumatoid arthritis, including avohilmo

571

8145

0.69

16.37

1.4

—

Hypothyroidism and >3 levothyroxin purchases

1234

8898

0.77

16.32

1.4

1.3

—

Hypothyroidism, levothyroxine purchases

1234

8898

0.77

16.32

1.4

1.3

—

Chronic pancreatitis

114

2460

0.45

16.28

1.4

1.5

—

Other spirochaetal diseases

951

7177

1.35

16.28

1.5

1.4

—

Acetic acid derivatives and related substances

978

3784

1.36

16.26

1.4

1.3

—

Later onset COPD

1073

0.27

16.20

1.5

1.6

—

Invasive ventilation

1268

0.25

16.15

1.5

—

GI-bleeding

325

5180

0.62

16.12

1.4

—

Later onset COPD, excluding more controls

1034

0.27

16.05

1.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

130

1899

0.47

16.05

1.7

1.4

—

Viral hepatitis

108

2340

0.44

16.05

1.4

—

Volume depletion

1240

0.24

16.03

1.3

1.4

—

Other CVD (FINNGEN)

1714

0.42

16.02

1.6

1.5

—

Gout, idiopatic and unspecified

162

3107

0.51

16.00

1.6

1.5

—

Ascites

1215

0.24

15.99

1.3

1.5

—

Spirochaetal infections, other/unspecified

933

7043

1.35

15.95

1.5

1.4

—

COPD-related respiratory insufficiency

1120

0.21

15.84

1.6

1.5

—

Fracture of femur

157

2757

0.51

15.84

1.4

—

Nontraumatic intracranial haemmorrhage

131

2663

0.48

15.53

1.5

—

Other and unspecified dermatitis

1123

14367

0.77

15.50

1.4

—

Open wound of head

1178

14446

0.78

15.49

1.4

—

Alzheimer disease, excluding more controls

1038

0.33

15.42

1.4

1.5

—

Malignant neoplasm of bronchus and lung

1520

0.38

15.40

1.4

1.5

—

Other diseases of the digestive system

334

5211

0.63

15.09

1.4

—

DVT of lower extremities and pulmonary embolism

530

7522

0.69

15.09

1.4

1.5

—

Acute bronchitis

724

9607

0.73

15.07

1.4

—

Other arthrosis

1271

11098

0.78

15.07

1.5

—

Dorsopathies

3527

20653

0.86

14.93

1.4

—

Gingivitis and periodontal diseases

3220

19263

0.86

14.91

1.4

—

Disorders of psychological development

238

3681

0.58

14.79

1.3

1.2

—

Triptan medication for migraine, min. 3 purchases

2649

17223

1.19

14.72

1.4

—

Hyperkinetic disorders, excluding more controls

334

4900

0.63

14.63

1.3

1.2

—

Sulfasalazine

617

8496

0.71

14.58

1.4

—

Fracture of lower leg, including ankle

1293

15985

0.79

14.58

1.4

—

Hypothyroidism, drug reimbursement

510

5112

0.69

14.58

1.4

1.3

—

Cardiomyopathy

170

3108

0.54

14.53

1.4

1.5

—

Other disorders of glucose regulation and pancreatic internal secretion

1779

0.40

14.38

1.5

1.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

320

4969

0.63

14.29

1.4

—

Post-traumatic stress disorder

178

3159

0.54

14.26

1.3

—

Ill-defined and unknown causes of mortality

830

0.14

14.07

1.4

1.5

—

3475

20618

0.86

14.07

1.4

—

Medical observation and evaluation for suspected diseases and conditions

2251

13658

0.83

14.01

1.4

—

Cardiovascular diseases

2781

17396

0.85

13.98

1.4

1.3

—

Other respiratory disorders and diseases

135

2620

0.51

13.94

1.5

—

Other diseases of the respiratory system

135

2620

0.51

13.94

1.5

—

Pulmonary heart disease, diseases of pulmonary circulation

336

5139

0.65

13.90

1.4

1.5

—

Codeine

3277

20491

0.86

13.89

1.4

—

Fenamates

510

2398

1.47

13.89

1.4

1.3

—

Other/unspecified seropositive rheumatoid arthritis

325

4997

0.64

13.87

1.4

—

Polyarthrosis

201

3218

0.57

13.85

1.5

—

Dissocial personality disorder

542

0.14

13.85

1.3

1.4

—

Hypokalaemia

101

2146

0.46

13.83

1.5

1.4

—

Intestinal stricture

350

5299

0.65

13.80

1.4

1.5

—

Cardiomyopathy (excluding other)

2102

0.46

13.74

1.4

1.5

—

Seropositive rheumatoid arthritis, wide

332

5068

0.65

13.70

1.4

—

Pneumonitis due to solids and liquids

1015

0.23

13.70

1.4

1.5

—

Continuous positive airway pressure

410

5042

0.67

13.60

1.4

—

Gout, unspecified

124

2450

0.50

13.55

1.7

1.5

—

Respiratory insufficiency

885

0.19

13.43

1.6

1.5

—

Other and unspecified mood [affective] disorders

141

2625

0.52

13.39

1.4

1.3

—

Coronary artery bypass grafting

150

2086

0.53

13.38

1.7

1.5

—

Primary gonarthrosis, bilateral

675

7779

0.74

13.34

1.5

—

Hernia

2677

20845

0.85

13.26

1.5

1.4

—

Cardiomyopathies, Primary/intrinsic

2032

0.46

13.24

1.4

1.5

—

Biological medication for rheuma

396

5758

0.67

13.16

1.4

—

Injuries to the elbow and forearm

1862

19522

0.83

13.12

1.4

—

Other blood glucose lowering drugs, excl. Insulins

121

2377

0.50

13.09

1.6

1.5

—

Certain infectious and parasitic diseases

3413

19543

0.87

13.00

1.4

—

Lung diseases due to external agents

1760

0.42

12.99

1.4

1.5

—

Mental disorders, not otherwise specified

151

2732

0.53

12.97

1.3

1.4

—

Delirium, not induced by alcohol and other psychoactive substances

1233

0.32

12.97

1.4

1.5

—

Peripheral arterial reconstruction

1312

0.34

12.92

1.4

1.5

—

Headache

2176

20429

0.84

12.89

1.4

—

Other mental disorders due to brain damage and dysfunction and to physical disease

1392

0.36

12.85

1.5

—

Transient ischemic attack

624

6842

0.73

12.83

1.6

1.5

—

Schizotypal disorder

793

0.18

12.82

1.2

1.4

—

Other disorders of urethra and urinary system

1630

14204

0.82

12.81

1.4

—

Neurological diseases

3188

18371

0.86

12.78

1.4

1.3

—

Other diseases of blood and blood-forming organs, wide

302

4623

0.64

12.75

1.5

1.4

—

Osteoporosis

191

3054

0.58

12.73

1.5

—

Lesion of ulnar nerve

222

3625

0.60

12.68

1.5

1.4

—

Mental and behavioural disorders due to tobacco

105

2119

0.48

12.67

1.5

1.4

—

Panic disorder

395

5697

0.68

12.63

1.4

1.3

—

Malignant neoplasm of breast, HER2-negative

941

7869

0.77

12.61

1.5

1.4

—

Symptoms and signs involving the digestive system and abdomen

3372

19285

0.87

12.51

1.4

—

Dilated cardiomyopathy

1783

0.44

12.51

1.4

1.5

—

Cardiac arrest

1070

0.33

12.50

1.9

1.5

—

274

4241

0.63

12.45

1.3

1.4

—

Smoking dependency

105

2105

0.48

12.42

1.5

1.4

—

Obesity, other/unspecified

923

11719

0.78

12.30

1.4

—

1125

13869

0.80

12.29

1.4

—

Other gastritis (incl. Duodenitis)

266

4155

0.63

12.28

1.4

1.5

—

Systemic connective tissue disorders

535

7337

0.72

12.26

1.5

1.4

—

Methotrexate

203

3362

0.59

12.22

1.4

—

Pulmonary embolism

323

4840

0.66

12.18

1.4

1.5

—

Nonischemic cardiomyopathy

1594

0.42

12.18

1.3

1.5

—

Pulmonary heart disease

323

4834

0.66

12.11

1.4

1.5

—

Falls/tendency to fall

3804

21525

0.88

12.10

1.4

—

All influenza

451

6332

0.70

12.08

1.4

—

N06DA Anticholinesterases

1382

0.44

12.05

1.4

1.5

—

Use of anticholinesterases

1382

0.44

12.05

1.4

1.5

—

Diseases of oral cavity, salivary glands and jaws

1717

10581

0.83

11.99

1.4

—

Other diseases of intestines

3579

23041

0.88

11.96

1.4

—

Varicose veins

1148

10760

0.80

11.95

1.4

1.5

—

Psoriasis

553

7488

0.73

11.83

1.5

1.4

—

Malignant neoplasm of breast

974

8017

0.78

11.76

1.5

1.4

—

Disorders of eyelid, lacrimal system and orbit

2134

18950

0.85

11.71

1.4

—

Asthma, hospital admissions , main diagnosis only

2340

23928

0.86

11.67

1.4

—

Paralytic ileus and intestinal obstruction

302

4532

0.66

11.53

1.4

1.5

—

Lumbar disc prolapse

1895

17121

0.84

11.53

1.5

1.4

—

Papulosquamous disorders

769

9919

0.77

11.52

1.5

1.4

—

Amputation of toe

760

0.19

11.45

1.5

—

Excluding asthma or asthma-COPD overlap

2876

16510

0.87

11.45

1.4

—

Psychotic depression

1721

0.46

11.44

1.4

—

Propionic acid derivatives

998

3945

1.29

11.35

1.4

1.3

—

Conjunctivitis

2990

21904

1.15

11.30

1.4

—

Benign neoplasm of colon, rectum, anus and anal canal

988

10742

0.79

11.28

1.5

—

Obesity related asthma

736

9506

0.76

11.22

1.5

1.4

—

Alzheimer disease

1074

0.41

11.20

1.3

1.5

—

Tobacco use

1344

0.39

11.20

1.1

1.4

—

Other pulmonary diagnosis

2881

16510

0.87

11.19

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

2050

21528

0.85

11.11

1.4

—

Other systemic involvement of connective tissue (FG)

405

5636

0.70

11.10

1.5

1.4

—

Other problems related to primary support group, including family circumstances

237

3583

0.63

11.07

1.4

1.3

—

Tumor necrosis factor alpha inhibitors

366

5221

0.69

11.05

1.4

—

Social phobias

200

3217

0.60

11.03

1.3

—

COPD differential diagnosis

2871

16439

0.87

11.02

1.4

—

Polycystic ovarian syndrome, consortium definition

2094

14477

0.85

11.02

1.4

1.3

—

ILD differential diagnosis

2870

16431

0.87

11.01

1.4

—

Somatoform disorder

334

4845

0.68

10.98

1.5

1.4

—

Myocardial infarction, without ST-elevation

323

4325

0.68

10.90

1.6

1.5

—

Disease of hard tissues of teeth, NOS

1703

10571

0.83

10.80

1.4

—

Injuries to the thorax

871

10975

0.79

10.79

1.4

—

GASTRO-related operations

3106

17687

0.87

10.78

1.4

—

Any gastric operation

3106

17687

0.87

10.78

1.4

—

Intracerebral haemorrhage

1297

0.40

10.73

1.4

1.5

—

Combinations of oral blood glucose lowering drugs

411

5744

0.71

10.71

1.7

1.5

—

Diseases of the myoneural junction and muscle

110

2079

0.52

10.71

1.3

1.4

—

Noninfective enteritis and colitis

1136

13873

0.81

10.68

1.4

—

Hypoglycaemia, other or unspecified

1448

0.43

10.64

1.4

—

Decubitus ulcer and pressure area

654

0.16

10.63

1.5

—

Conduction disorders

349

4079

0.69

10.63

1.5

—

Maltreatment syndromes

1812

0.49

10.62

1.2

1.3

—

Special screening examination for infectious and parasitic diseases

1617

10034

1.21

10.62

1.3

—

Soft tissue disorders

3560

20617

0.88

10.61

1.4

—

Codeine or tramadol medication

3686

22624

0.89

10.59

1.4

—

Seropositive rheumatoid arthritis, strict definition

189

3070

0.60

10.56

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1201

13074

0.82

10.52

1.5

1.4

—

Generalized anxiety disorder

444

6078

0.72

10.49

1.3

—

Symptoms and signs concerning food and fluid intake

111

2071

0.52

10.45

1.6

1.4

—

Diabetic neuropathy

1040

0.34

10.43

1.5

1.6

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1025

8209

0.80

10.40

1.5

1.4

—

Malignant neoplasm of breast, including Hilmo

1026

8209

0.80

10.33

1.5

1.4

—

Neurological diseases, wide definition

1374

8297

0.82

10.32

1.4

1.3

—

Injuries to the hip and thigh

762

8799

0.78

10.27

1.4

—

Other or unspecified ileus, impaction or obstruction

180

2942

0.60

10.22

1.4

1.5

—

Other diseases of hard tissues of teeth

1735

10580

0.84

10.16

1.4

—

Alcohol-induced chronic pancreatitis

1431

0.44

10.15

1.5

—

L01XE Protein kinase inhibitors

726

0.23

10.09

1.1

1.5

—

Vocal cord dysfunction

356

4510

0.69

10.07

1.4

—

Nonorganic sleeping disorders

489

6562

0.73

10.06

1.4

1.3

—

Extreme obesity with alveolar hypoventilation

796

0.27

9.99

1.2

1.4

—

Hyperkalaemia

624

0.17

9.98

1.5

1.4

—

Other arthritis (FG)

669

8610

0.77

9.97

1.4

—

Haemorrhage from respiratory passages

507

6122

0.74

9.93

1.4

—

Fitting and adjustment of other devices

389

4903

0.71

9.92

1.4

1.5

—

Gonarthrosis, primary, with knee surgery

779

7859

0.78

9.85

1.5

—

Alzheimer disease, including avohilmo

1286

0.51

9.80

1.4

1.5

—

Brachial plexus disorders

204

3177

0.62

9.79

1.3

1.4

—

Radiculopathy

201

3162

0.63

9.75

1.4

—

Gout, strict definition

112

2049

0.54

9.70

1.7

1.5

—

Speech and linguistic disorders, excluding more controls

172

2618

0.60

9.68

1.3

1.2

—

Adrenocortical insufficiency

747

0.26

9.65

1.4

—

Other enthesopathies

738

9339

0.78

9.65

1.5

1.4

—

Osteomyelitis

1057

0.37

9.65

1.5

—

Trigger finger

258

3832

0.66

9.64

1.5

1.4

—

Acute pancreatitis

278

4075

0.67

9.58

1.4

1.5

—

Thiazolidinediones

1624

0.49

9.52

1.7

1.5

—

Other and unspecified myopathies

1292

0.43

9.46

1.4

1.5

—

Disorders of conjunctiva

3159

22576

1.13

9.45

1.4

—

Wide developmental disorders, excluding more controls

1056

0.38

9.40

1.3

—

Obsessive-compulsive disorder

143

2392

0.58

9.35

1.4

1.3

—

Secondary parkinsonism, excluding more controls

364

0.13

9.32

1.0

1.4

—

Non-small cell lung cancer, including Hilmo

1422

0.48

9.27

1.5

—

Weight loss

1618

0.50

9.23

1.7

1.4

—

Cervical disc disorders

768

9631

0.79

9.22

1.5

—

Anti-inflammatory and antirheumatic products, non-steroids

975

3945

1.25

9.21

1.3

—

Paroxysmal tachycardia

583

6317

0.76

9.14

1.4

—

Chronic ulcer of skin, not elsewhere classified

971

0.36

9.07

1.5

1.4

—

Other functional intestinal disorders

883

10112

0.80

9.05

1.4

—

Cervicobrachial syndrome

507

6666

0.75

9.03

1.4

—

Hyperkinetic disorders

334

4561

0.70

8.98

1.3

—

Adenocarcinoma and ductal carcinoma of pancreas

354

0.14

8.96

1.0

1.5

—

Implicit fungal Sepsis

1106

0.41

8.93

1.3

1.4

—

Special screening examination for other diseases and disorders

192

2978

0.63

8.91

1.2

1.4

—

Duodenal ulcer

1238

0.44

8.91

1.4

1.5

—

Gastric ulcer

139

2336

0.59

8.87

1.4

1.5

—

Malignant neoplasm of pancreas

673

0.25

8.86

1.5

—

Other specified/unspecified arthritis

583

7511

0.77

8.84

1.4

—

Malignant neoplasm of pancreas, including Hilmo

917

0.35

8.81

1.6

1.5

—

776

0.31

8.80

1.3

1.4

—

Injuries to the shoulder and upper arm

2268

20803

0.87

8.79

1.4

—

Acute pancreatitis (for exclusion)

278

4007

0.68

8.79

1.4

1.5

—

Other disorders of adrenal gland

931

0.36

8.71

1.3

1.4

—

Disturbance of activity and attention

322

4401

0.70

8.69

1.3

1.2

—

Fibrosis and cirrhosis of liver

1204

0.44

8.66

1.4

1.5

—

Intestinal infectious diseases

2860

24341

0.89

8.66

1.4

—

Cellulitis

418

5612

0.73

8.61

1.4

—

Unspecified kidney failure

1066

0.41

8.59

1.3

1.5

—

Agranulocytosis

128

2167

0.58

8.58

1.5

1.4

—

Polyneuropathies and other disorders of the peripheral nervous system

238

3517

0.67

8.56

1.5

—

Arthropathies in other diseases classified elsewhere

800

0.32

8.50

1.3

1.4

—

Inflammatory bowel disease

811

9998

0.80

8.45

1.3

1.4

—

Unspecified haematuria

598

6354

0.77

8.45

1.5

—

Gastro-oesophageal reflux disease

1773

17648

0.86

8.44

1.5

1.4

—

Suppurative and unspecified otitis media

1183

12465

0.83

8.43

1.3

—

Dementia in Alzheimer disease

529

0.24

8.41

1.3

1.5

—

Abdominal and pelvic pain

3454

19285

0.89

8.41

1.4

—

Secondary parkinsonism+Parkinsonism in other disease

337

0.14

8.34

1.0

1.4

—

Fungal Sepsis

642

0.26

8.33

1.1

1.5

—

Unspecified fall

1064

12585

0.83

8.33

1.4

—

Other specific joint derangements/joint disorders

2599

18906

0.88

8.31

1.4

—

IBD patients in KELA-register

609

7728

0.78

8.30

1.3

1.4

—

Non-small cell lung cancer

838

0.35

8.22

1.3

1.5

—

Acute peritonitis

1039

0.41

8.21

1.4

—

Persons encountering health services for examination and investigation

2404

13658

0.88

8.21

1.4

—

Dislocation, sprain and strain of joints and ligaments of knee

2549

20870

1.14

8.19

1.4

—

Cerebral palsy and other paralytic syndromes

151

2425

0.61

8.19

1.4

—

Other systemic involvement of connective tissue

417

5565

0.74

8.18

1.5

1.4

—

Glaucoma

747

7996

0.80

8.18

1.5

—

Secondary parkinsonism

333

0.15

8.18

1.0

1.4

—

Recurrent or chronic depression

1501

12299

0.85

8.18

1.4

—

Disorders of synovium and tendon

1574

15991

0.85

8.15

1.4

—

Autism spe, excluding more controls

846

0.36

8.11

1.3

—

Ventral hernia

347

4749

0.72

8.07

1.5

—

Intentional self-harm by sharp object

772

0.33

8.06

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

765

9349

0.80

8.05

1.4

—

Inflammatory bowel disease, strict (require KELA)

609

7697

0.78

8.04

1.3

1.4

—

Other (seronegative) rheumatoid arthritis, wide

242

3514

0.68

8.00

1.4

—

Agoraphobia

1148

0.45

7.97

1.3

—

Other diseases of upper respiratory tract

4018

19002

1.11

7.97

1.4

—

Bronchitis

3339

23304

0.90

7.97

1.4

—

Pain (limb, back, neck, head abdominally)

2593

14623

0.88

7.96

1.4

—

Abnormal weight loss

1408

0.50

7.96

1.7

1.4

—

Diagnoses used for exclusion with ILD

359

4876

0.73

7.94

1.5

1.4

—

Evidence of alcohol involvement determined by blood alcohol level

399

0.21

7.94

1.7

1.4

—

Crohn's disease NAS

1747

0.55

7.94

1.3

1.4

—

Disorders resulting from impaired renal tubular function

636

0.27

7.91

1.2

1.4

—

Cirrhosis of liver, NAS

745

0.33

7.86

1.4

1.5

—

Psoriasis vulgaris

347

4718

0.72

7.86

1.4

—

Hallux valgus (acquired)

725

6475

0.80

7.85

1.4

—

Fracture of rib(s), sternum and thoracic spine

468

6109

0.76

7.84

1.4

—

Hydrocephalus

880

0.38

7.84

1.4

—

Superficial injury of head

450

5896

0.75

7.83

1.3

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1365

15745

0.85

7.82

1.4

—

Endometriosis

1240

6125

1.20

7.80

1.4

1.3

—

Charcot foot

378

0.20

7.80

1.5

1.4

—

Anaemia in chronic diseases classified elsewhere

318

0.15

7.75

1.6

1.3

—

Calcific aortic valvular stenosis, including rheumatic fever

152

2343

0.62

7.71

1.6

1.5

—

Adalimumab

206

3042

0.66

7.71

1.4

—

Dysphagia

369

4965

0.74

7.69

1.5

1.4

—

Calcific aortic valvular stenosis, diagnosis (helper)

151

2329

0.62

7.66

1.6

1.5

—

Operations 2 for CAVS

151

2329

0.62

7.66

1.6

1.5

—

Implicit fungal Sepsis

594

0.26

7.65

1.1

1.4

—

Toxic effect of ethanol

1149

0.46

7.65

1.1

1.4

—

Fracture of forearm

1311

14054

0.85

7.64

1.3

1.4

—

Adhesive capsulitis of shoulder

278

3898

0.70

7.62

1.5

—

Paranoid personality disorder

502

0.21

7.62

1.1

1.4

—

Traumatic subdural haemorrhage

1673

0.56

7.62

1.4

1.5

—

AV-block

120

1765

0.59

7.61

1.6

1.5

—

Deforming dorsopathies

618

7756

0.79

7.61

1.4

—

Persons encountering health services for specific procedures, not carried out

147

2325

0.62

7.60

1.4

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

530

0.23

7.59

1.2

1.3

—

Alzheimer’s disease (Late onset), excluding more controls

548

0.37

7.58

1.3

1.5

—

Calcific aortic valvular stenosis, operated

152

2335

0.63

7.58

1.6

1.5

—

Calcific aortic valvular stenosis

152

2335

0.63

7.58

1.6

1.5

—

Assault by unspecified means

698

0.32

7.53

1.2

1.4

—

Specific development disorders of scholastic skills

1362

0.51

7.53

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

162

2515

0.64

7.52

1.3

1.5

—

Psoriatic and enteropathic arthropathies

230

3317

0.68

7.52

1.4

—

Parkinson's disease, excluding more controls

1552

0.55

7.51

1.4

1.5

—

Diseases of the skin and subcutaneous tissue

3547

19624

0.90

7.49

1.4

—

Dissociative [conversion] disorders

1153

0.47

7.49

1.3

—

Unspecified jaundice

751

0.35

7.38

1.3

1.5

—

Elevated blood glucose level

1690

0.56

7.35

1.4

—

Other abnormal uterine and vaginal bleeding

377

3608

0.74

7.35

1.4

1.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

112

1878

0.59

7.31

1.3

1.4

—

Other and unspecified polyneuropathies, also in other diseases

197

2922

0.67

7.30

1.5

—

Familial hypercholesterolemia

109

1847

0.58

7.28

1.4

1.5

—

Assault by bodily force

189

2799

0.66

7.28

1.2

1.4

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

247

0.16

7.25

1.0

1.4

—

Status epilepticus

680

0.33

7.22

1.5

1.4

—

Pleural effusion

1716

0.57

7.21

1.4

1.5

—

Diabetes mellitus in pregnancy

1323

9856

0.85

7.21

1.3

—

Disorders of other endocrine glands

1003

11735

0.83

7.20

1.4

—

Dependent personality disorder

485

0.22

7.20

1.2

1.4

—

Antihypertensive medication - note that there are other indications

2749

16224

0.89

7.19

1.4

1.3

—

Infective dermatitis

162

2482

0.64

7.17

1.3

1.4

—

Emotional disorders starting during childhood or adolecense, excluding more controls

1464

0.54

7.14

1.2

—

Spondyloarthritis

365

4848

0.74

7.11

1.3

1.4

—

Manic episode

856

0.40

7.10

1.4

—

5-aminosalicylic acid

577

7220

0.79

7.05

1.3

1.4

—

Fall on same level involving ice and snow

1392

16098

0.86

7.02

1.4

—

Retinal breaks without detachment

403

3056

1.34

7.01

1.5

—

Pacemaker

212

2955

0.68

7.00

1.6

1.5

—

Pre-eclampsia or poor fetal growth

948

11234

0.83

6.98

1.3

—

Myocardial infarction, unclassifiable

105

1590

0.59

6.96

1.5

—

Drug-induced adrenocortical insufficiency

369

0.23

6.96

1.6

1.4

—

Emphysema

833

0.40

6.95

1.5

—

Wide developmental disorders

944

0.44

6.94

1.3

—

Fracture of lumbar spine and pelvis

233

3312

0.70

6.93

1.4

—

Malignant neoplasm of oesophagus

295

0.17

6.93

1.8

1.5

—

Autism

816

0.40

6.91

1.3

—

Speech and linguistic disorders

173

2481

0.65

6.87

1.3

1.2

—

Mixed specific developmental disorders

437

0.22

6.86

1.2

—

Zoster [herpes zoster]

203

2953

0.68

6.84

1.4

—

Autism spe

783

0.39

6.82

1.3

—

Otitis media, unspecified

223

2924

0.69

6.79

1.3

—

Ulcerative colitis

606

7510

0.80

6.77

1.3

1.4

—

Subarachnoid haemorrhage

1592

0.57

6.76

1.5

—

Arthropathies

3464

19268

0.91

6.74

1.4

—

DVT of lower extremities

244

3426

0.70

6.74

1.4

1.5

—

Iron deficiency anaemia secondary to blood loss (chronic)

172

2575

0.66

6.73

1.4

—

Other CVD

137

2154

0.63

6.72

1.6

1.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

183

2690

0.67

6.72

1.6

1.5

—

Asthma, including avohilmo

3867

23702

0.91

6.69

1.4

—

Mixed disorders of conduct and emotions, excluding more controls

789

0.40

6.68

1.4

1.2

—

Crohn disease

284

3869

0.72

6.67

1.3

1.4

—

Noninflammatory disorders of female genital tract

1541

6705

1.16

6.66

1.3

—

Acute alcohol intoxication ICD-9

577

0.30

6.65

1.6

1.5

—

Fall on and from stairs and steps

480

6101

0.78

6.64

1.4

—

Other headache syndromes

1200

13946

0.85

6.64

1.4

—

Disorders of parathyroid gland

210

2984

0.69

6.64

1.5

1.4

—

Pain in joint

2005

14407

0.88

6.62

1.4

—

Colorectal cancer

211

2965

0.69

6.60

1.4

1.5

—

Sequelae of external causes of morbidity and mortality

408

5290

0.76

6.60

1.5

1.4

—

Trochanteric bursitis

217

3091

0.69

6.59

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

218

3112

0.69

6.59

1.4

1.5

—

Exclusions for E4_PCOS_CONSORTIUM

2302

16110

0.89

6.56

1.4

1.3

—

Other/unspecified rheumatoid arthritis

108

1778

0.60

6.53

1.4

—

Coxarthrosis, primary

828

8419

0.83

6.49

1.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1717

9798

0.87

6.47

1.4

1.3

—

Medical treatment for female infertility

1024

8661

1.19

6.46

1.3

—

Abnormal findings on examination of blood, without diagnosis

787

8701

0.82

6.45

1.5

1.4

—

Suppurative and necrotic conditions of lower respiratory tract

857

0.43

6.42

1.5

—

Drug-induced neutropenia

1321

0.54

6.41

1.6

1.4

—

Myocardial infarction, with ST-elevation

118

1897

0.62

6.40

1.5

—

Other and unspecified psoriasis

1332

0.54

6.39

1.5

1.4

—

Unspecified human immunodeficiency virus [HIV] disease

311

0.21

6.38

1.1

1.4

—

Cardiomyopathy, other and unspecified

1334

0.54

6.37

1.4

1.5

—

Pain in thoracic spine

343

4517

0.75

6.37

1.4

—

Drug-induced hypoglycaemia without coma

279

0.17

6.37

2.6

1.3

—

Cholecystitis

135

2097

0.64

6.34

1.4

1.5

—

Neuromuscular dysfunction of bladder

103

1698

0.60

6.34

1.7

1.4

—

Fracture of shoulder and upper arm

685

8323

0.82

6.32

1.4

—

Secondary uncertain malignant neoplasm

114

1838

0.61

6.32

1.3

1.5

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1511

0.58

6.31

1.2

—

Fracture of foot, except ankle

621

7613

0.81

6.30

1.3

1.4

—

Degeneration of nervous system due to alcohol

316

0.21

6.28

1.3

1.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

723

8736

0.82

6.28

1.3

1.4

—

Abnormal involuntary movements

201

2874

0.69

6.28

1.4

—

Explicit bacterial Sepsis

121

1917

0.62

6.28

1.3

1.4

—

Degeneration of the brain due to alcohol

317

0.21

6.27

1.3

1.5

—

Adenocarcinoma and papillary adenocarcinoma of stomach

279

0.18

6.26

1.8

1.5

—

Aortic valve malfunction, age under 60 years

171

2509

0.67

6.26

1.6

1.5

—

Viral pneumonia

203

2895

0.69

6.25

1.5

1.4

—

Hernia of abdominal wall, postoperative

346

4545

0.75

6.25

1.5

1.4

—

Behavioural disorders, excluding more controls

761

0.41

6.22

1.2

1.3

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2127

15048

1.13

6.20

1.3

1.4

—

Intestinal malabsorption

1029

0.49

6.19

1.4

—

Acute suppurative otitis media

913

10053

0.84

6.17

1.3

—

Lateral epicondylitis

323

4263

0.74

6.17

1.5

1.4

—

Streptococcal septicaemia

1449

0.57

6.17

1.3

1.4

—

Amputation of thigh

156

0.00

6.16

0.0

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

706

5818

0.82

6.15

1.5

—

Sequelae of injuries, of poisoning and of other consequences of external causes

553

6844

0.80

6.15

1.4

—

severe traumatic brain injury, does not include concussion

250

3442

0.72

6.14

1.4

1.5

—

Disorders of continuity of bone

175

2549

0.67

6.14

1.4

—

Other diseases of pancreas

1369

0.56

6.13

1.4

1.5

—

Other and unspecified drugs and medicaments

111

1779

0.61

6.12

1.4

—

Other symptoms and signs involving general sensations and perceptions

698

0.39

6.11

1.5

1.4

—

Colorectal adenocarcinoma

155

2317

0.66

6.11

1.5

—

Episodal and paroxysmal disorders

3803

21058

0.91

6.09

1.4

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1068

0.51

6.08

1.3

1.5

—

Other condition

290

3882

0.74

6.08

1.3

1.4

—

Gastrointestinal diseases

2535

14078

0.90

6.08

1.4

1.3

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

129

1995

0.63

6.07

1.5

1.4

—

Covid-19 confirmed case

665

8078

0.82

6.07

1.5

1.4

—

Oesophageal varices

636

0.37

6.02

1.3

1.5

—

Other Crohn's disease

135

2056

0.64

6.01

1.2

1.4

—

Other noninfective gastroenteritis and colitis

458

5772

0.78

5.99

1.5

1.4

—

Spondylopathies (FG)

345

4494

0.76

5.99

1.3

1.4

—

Disorders of thyroid, IBD co-morbidities

665

5670

0.81

5.98

1.5

1.3

—

Hyperparathyroidism

177

2544

0.68

5.98

1.5

—

Malignant neoplasm of breast, ER-positive, including Hilmo

667

6246

0.82

5.98

1.5

1.4

—

Human immunodeficiency virus [HIV] disease

593

0.35

5.97

1.1

1.4

—

Vitreous haemorrhage

112

1783

0.62

5.97

1.6

1.4

—

Hepatic failure, not elsewhere classified

632

0.37

5.96

1.2

1.4

—

Diseases of peritoneum

113

1794

0.62

5.95

1.4

—

Meniscus derangement

1598

12208

0.88

5.94

1.5

1.4

—

Psoriatic arthropathies

194

2756

0.69

5.94

1.5

1.4

—

Non-small cell lung cancer, squamous

267

0.19

5.92

1.4

1.5

—

Dental pulpitis, including avohilmo

3343

23656

0.91

5.90

1.3

1.4

—

Noninfectious colitis NAS

232

3200

0.71

5.89

1.5

1.4

—

Diseases of the musculoskeletal system and connective tissue

2314

12900

0.89

5.88

1.4

1.3

—

Endometriosis of pelvic peritoneum

615

4794

1.24

5.87

1.4

1.3

—

Non-allergic asthma (mode), excluding more controls

378

4814

0.77

5.83

1.3

1.4

—

Hyperplasia of prostate

616

4286

0.81

5.82

1.5

—

Assault by sharp object

570

0.35

5.81

1.5

1.4

—

Myocarditis

1450

0.58

5.79

1.4

—

Outcome of delivery

874

4561

1.21

5.78

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

3780

20558

0.92

5.76

1.4

—

Ulcerative colitis, NAS

301

3972

0.75

5.74

1.3

1.4

—

Unspecified acute lower respiratory infection

297

3928

0.75

5.72

1.4

—

Idiopathic gout

1075

0.52

5.71

1.6

1.5

—

Mixed disorders of conduct and emotions

739

0.43

5.70

1.4

1.2

—

Benign neoplasm: Colon

786

8929

0.84

5.69

1.5

—

Abnormal findings on diagnostic imaging of lung

675

7805

0.82

5.69

1.5

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

275

0.21

5.67

1.2

1.4

—

Alzheimer’s disease, strict definition

869

0.52

5.66

1.4

1.5

—

Schizoid personality disorder

475

0.30

5.63

1.5

1.4

—

Failure and rejection of transplanted organs and tissues

293

0.23

5.63

1.0

1.4

—

Demyelinating diseases of the central nervous system

189

2665

0.69

5.63

1.4

—

Other pleural conditions

1058

0.52

5.63

1.4

1.5

—

Aneurysms, operations, SAH

222

3063

0.72

5.62

1.5

—

Other infectious diseases

101

1622

0.61

5.62

1.4

—

Anankastic personality disorder

1209

0.55

5.62

1.4

—

Poor fetal growth

390

4948

0.77

5.61

1.3

—

Malignant neoplasm of breast, HER-positive

647

6099

0.82

5.59

1.5

1.4

—

Hypothyroidism, strict autoimmune

2272

16552

0.90

5.59

1.4

—

Seronegative rheumatoid arthritis

162

2354

0.68

5.58

1.3

1.4

—

Algoneurodystrophy

921

0.49

5.56

1.2

1.4

—

Parkinson's disease, strict definition, excluding more controls

1380

0.59

5.54

1.4

1.5

—

Emotional disorders starting during childhood or adolescence

1384

0.59

5.53

1.2

—

Other disorders of the musculoskeletal system and connective tissue

208

2889

0.71

5.52

1.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

265

3553

0.74

5.52

1.4

1.5

—

Abnormalities of gait and mobility

1581

0.61

5.52

1.4

1.5

—

Pyothorax

653

0.40

5.51

1.6

1.4

—

Oxicams

632

2936

1.23

5.49

1.5

1.3

—

Myalgia

611

7392

0.82

5.49

1.4

—

Hernia of abdominal wall

946

11038

0.85

5.48

1.5

1.4

—

Hydronephrosis

126

1917

0.65

5.47

1.3

1.4

—

Non-allergic asthma (mode)

378

4772

0.78

5.46

1.3

1.4

—

Crohn's disease of large intestine

1440

0.59

5.45

1.3

1.4

—

All influenza (not pneumonia)

311

4055

0.76

5.43

1.4

—

Other diseases of liver

344

4427

0.77

5.41

1.5

1.4

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

550

0.36

5.40

1.1

1.4

—

Malignant neoplasm of brain, including Hilmo

1022

0.53

5.39

1.3

1.4

—

Drug-induced cataract

467

0.31

5.38

1.5

1.4

—

Blood alcohol or alcohol intoxication level

680

0.42

5.37

1.2

1.4

—

Conduct disorder

703

0.44

5.31

1.2

1.3

—

Malignant neoplasm of stomach

530

0.35

5.31

1.5

—

Malignant neoplasm of skin

804

6518

0.84

5.31

1.5

—

644

0.41

5.31

1.1

1.4

—

malignant neoplasm of male genital organs

388

3013

0.78

5.30

1.6

1.5

—

Unspecified dementia

384

0.28

5.29

1.3

1.5

—

Neovascular glaucoma

612

0.40

5.27

1.5

1.4

—

Caries of enamel

3484

23189

1.09

5.26

1.3

1.4

—

Bell's palsy

197

2733

0.71

5.25

1.4

—

Hypotension

101

1600

0.63

5.23

1.6

1.5

—

Adjustment and management of implanted device

140

2070

0.67

5.22

1.6

1.5

—

Deviated nasal septum

1046

9047

1.17

5.21

1.6

1.4

—

Hypermobility syndrome

113

1725

0.64

5.20

1.4

—

Persons with potential health hazards related to communicable diseases

1307

14689

0.87

5.19

1.4

1.3

—

Paracetamol or NSAID medication

699

2923

1.22

5.18

1.3

—

Use of memantine

848

0.54

5.17

1.4

1.5

—

Use of other anti-dementia drugs

848

0.54

5.17

1.4

1.5

—

Injuries to the ankle and foot

2421

23609

0.91

5.17

1.3

1.4

—

Glaucoma secondary to other eye disorders

606

0.40

5.15

1.5

1.4

—

Diseases of the ear and mastoid process

4167

22513

0.93

5.15

1.4

—

Glomerulonephritis

135

1994

0.67

5.13

1.5

1.4

—

Soft tissue disorders related to use, overuse and pressure

570

6899

0.82

5.13

1.5

1.4

—

MS-disease / Multiple Sclerosis

160

2278

0.69

5.10

1.3

1.4

—

Malignant neoplasm of oesophagus, including Hilmo

442

0.31

5.08

2.1

1.5

—

Contraceptive management

1887

11896

1.12

5.06

1.4

—

ILD, hospital admission 2, with pulmonary infections

1187

0.57

5.06

1.8

1.5

—

Assault by blunt object

460

0.33

5.05

1.1

1.4

—

Other follicular disorders

150

2155

0.68

5.02

1.4

—

Other disorders starting during childhood or adolecense, excluding more controls

101

1502

0.63

5.02

1.3

1.2

—

Endometriosis of ovary

559

4493

1.23

5.02

1.4

1.3

—

Cytomegalovirus infection, IBD co-morbidity

478

0.34

5.01

1.5

1.4

—

Endovascular or surgical operations to intracerebral aneurysms

1140

0.57

5.00

1.5

—

Malignant neoplasm of colon, including Hilmo

159

2272

0.69

4.98

1.4

1.5

—

Malignant neoplasm of stomach, including Hilmo

628

0.42

4.98

1.4

1.5

—

Alzheimer’s disease (Atypical or mixed)

239

0.21

4.98

1.0

1.5

—

Exclusions for E4_PCOS_BROAD

365

4606

0.78

4.98

1.4

—

Other diseases of spinal cord

621

0.42

4.97

1.2

1.4

—

Arterial embolism and thrombosis

599

0.41

4.97

1.4

1.5

—

Undefined dementia

379

0.29

4.97

1.3

1.5

—

Personal history of risk-factors, not elsewhere classified

367

0.26

4.97

1.2

1.3

—

Systemic atrophies primarily affecting the central nervous system

582

0.40

4.96

1.5

1.4

—

Vitamin deficiency

944

0.53

4.96

1.4

—

Vitamin deficiency, wide

944

0.53

4.96

1.4

—

Nonalcoholic fatty liver disease

186

2569

0.71

4.91

1.5

1.4

—

Alcoholic gastritis

253

0.23

4.90

2.7

1.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

193

2657

0.72

4.89

1.4

—

Other sleep disorders

204

2778

0.72

4.88

1.4

—

Habit and impulse disorders

552

0.40

4.86

1.2

1.4

—

Non-small cell lung cancer, squamous, helper endpoint

236

0.21

4.86

1.4

1.5

—

Tonsillectomy and adenotomy

2760

17634

1.10

4.81

1.3

—

Mucosal proctocolitis

313

4002

0.77

4.80

1.3

1.4

—

Haemorrhage in early pregnancy

841

9511

0.85

4.80

1.3

—

Spondylolisthesis/Spondylolysis

357

4501

0.78

4.79

1.4

—

Other disorders of breast

404

3240

1.27

4.75

1.4

—

Vascular dementia

247

0.23

4.74

1.5

—

Behavioural disorders

685

0.46

4.73

1.2

1.3

—

Osteonecrosis

1071

0.57

4.72

1.6

1.5

—

Diplopia

190

2604

0.72

4.72

1.4

—

Sequelae with surgical and medical care as external cause

296

3814

0.77

4.72

1.5

1.4

—

Arthropathic psoriasis

208

2806

0.73

4.71

1.5

1.4

—

Migraine without aura

678

7992

0.84

4.69

1.4

1.3

—

Malignant neoplasm of eye, brain and central nervous system

874

0.53

4.68

1.3

1.4

—

Spinal instabilities

712

0.48

4.68

1.5

1.4

—

Disorders of calcium metabolism

1094

0.57

4.68

1.5

1.4

—

Disorders of skin appendages

1410

15796

0.89

4.67

1.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2422

17884

0.91

4.65

1.4

—

Corns and callosities

1266

0.60

4.65

1.5

1.4

—

Dysplasia of cervi uteri

948

5941

1.17

4.65

1.3

—

Psoriatic arthropathies, ICD10

192

2614

0.72

4.64

1.5

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

437

0.34

4.63

1.4

1.5

—

Poisoning by medicine, drug-induced

366

0.28

4.63

2.0

1.4

—

Alcohol-induced acute pancreatitis

803

0.51

4.62

1.5

—

Mycoses

515

6225

0.82

4.62

1.4

—

Communicating hydrocephalus

280

0.28

4.61

1.5

1.4

—

Colectomy operation

187

2562

0.72

4.60

1.3

1.5

—

Non-small cell lung cancer, adenocarcinoma

565

0.42

4.59

1.3

1.5

—

Preterm labour and delivery

679

7991

0.84

4.59

1.3

1.4

—

Plantar fascial fibromatosis

199

2689

0.73

4.59

1.4

—

Somnolence, stupor and coma

803

0.51

4.57

1.5

1.4

—

Personal history of certain other diseases

594

0.44

4.56

1.4

1.3

—

Use of levodopa decarboxylase inhibitor

1067

0.58

4.56

1.5

—

KRA_PSY_EATING, excluding more controls

255

3298

0.75

4.54

1.3

—

Injury, poisoning and certain other consequences of external causes

2076

11463

0.90

4.52

1.4

—

Other complications of surgical and medical care, not elsewhere classified

163

2268

0.71

4.51

1.4

—

Juvenile arthritis (FINNGEN)

1432

0.63

4.50

1.3

—

Procreative management

1430

10644

1.13

4.50

1.4

—

Disorders of mineral metabolism

109

1632

0.66

4.50

1.5

1.4

—

Malignant neoplasm of brain

743

0.50

4.49

1.3

1.4

—

Speech disturbances, not elsewhere classified

1294

0.62

4.48

1.3

1.4

—

Superficial injury of wrist and hand

540

6469

0.83

4.48

1.4

—

Other psoriatic arthropathies

188

2552

0.72

4.47

1.5

1.4

—

Attention to artificial openings

514

0.40

4.47

1.2

1.5

—

Other endocrine disorders

1056

0.59

4.46

1.3

—

Other inflammatory liver diseases

1373

0.63

4.46

1.4

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

968

0.56

4.45

1.5

1.4

—

malignant neoplasm of female genital organs

158

2197

0.71

4.44

1.5

1.4

—

Strabismus

622

7335

0.84

4.41

1.3

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1280

14373

0.88

4.40

1.4

—

External causes of morbidity and mortality

2513

13730

0.91

4.39

1.4

—

Chronic hepatitis, not elsewhere classified

737

0.50

4.39

1.6

1.4

—

Use of glatiramer acetate

555

0.43

4.39

1.2

1.4

—

Paralytic strabismus

1162

0.60

4.39

1.3

1.4

—

Flat foot [pes planus] (acquired)

167

2303

0.71

4.39

1.4

—

Extrapyramidal and movement disorders

568

6776

0.83

4.38

1.5

1.4

—

Hidradenitis suppurativa

1151

0.60

4.37

1.2

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1970

13528

1.11

4.36

1.3

1.4

—

Other respiratory diseases principally affecting the interstitium

147

2077

0.70

4.36

1.7

1.5

—

Mixed connective tissue disease

1353

0.63

4.36

1.6

1.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

414

5069

0.81

4.34

1.3

1.4

—

Other joint disorders

3392

19253

0.92

4.33

1.4

—

Other necrotizing vasculopathies

983

0.57

4.32

1.3

1.4

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

220

0.22

4.31

1.4

1.5

—

Budesonide

322

4048

0.79

4.30

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions

1056

11979

0.87

4.30

1.4

—

Causalgia

454

0.38

4.28

1.1

1.4

—

Ulcerative colitis (strict definition, require KELA)

430

5236

0.81

4.28

1.3

1.4

—

Other and unspecified disorders of psychological development

263

0.29

4.28

1.4

1.3

—

Crohn disease (strict definition, all UC cases excluded)

1427

0.64

4.27

1.2

1.4

—

Other diseases of biliary tract

1266

0.62

4.27

1.3

1.5

—

Other disorders of eye and adnexa

285

3632

0.77

4.27

1.4

—

Other specified/unspecified soft tissue disorders

913

0.56

4.25

1.4

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

143

2006

0.70

4.25

1.2

1.4

—

Cytomegaloviral disease

510

0.42

4.22

1.5

1.4

—

Malignant neoplasm of prostate, including Hilmo

384

2831

0.80

4.22

1.5

1.6

—

Injury of other and unspecified intrathoracic organs

1270

0.63

4.21

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

666

0.49

4.20

1.4

1.5

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

468

5642

0.82

4.20

1.3

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

901

0.56

4.20

1.9

1.5

—

Disorder of lipoprotein metabolism, unspecified

129

1849

0.69

4.19

1.8

1.5

—

Malignant neoplasm of prostate

340

2555

0.79

4.18

1.6

—

Motor neuron disease

283

0.31

4.17

1.7

1.4

—

Cholecystectomy

1688

16082

0.90

4.17

1.4

—

Sequelae of injuries of head

1336

0.64

4.16

1.4

—

Toxic effects of substances chiefly nonmedicinal as to source

242

3135

0.76

4.16

1.4

—

Unknown and unspecified causes of morbidity

120

1733

0.68

4.16

1.4

—

Familial hypercholesterolemia, with ischemic heart disease

796

0.53

4.15

1.7

1.5

—

Other infectious diseases

1292

0.63

4.14

1.4

—

Previous suicide attempt

279

0.31

4.14

1.2

1.3

—

Pure hyperglyceridaemia

422

0.37

4.14

1.4

—

Ankylosing spondylitis

189

2529

0.73

4.14

1.3

1.4

—

Brain glioblastoma

246

0.27

4.13

1.3

1.5

—

Ocular pain

156

2149

0.71

4.13

1.4

—

Complications of labour and delivery

2180

11074

1.10

4.13

1.4

—

Artrosis, including avohilmo

2792

16532

0.92

4.13

1.5

1.4

—

Hyperkinetic disorders (excl. ADHD)

511

0.43

4.11

1.4

1.3

—

530

0.44

4.10

1.3

1.2

—

Malignant neoplasm, without specification of site, including Hilmo

453

0.39

4.10

1.6

1.5

—

Other/unspecified cytomegaloviral diseases

417

0.37

4.08

1.6

1.4

—

Valvular operations

147

2049

0.71

4.07

1.6

1.5

—

Infections of genitourinary tract in pregnancy

212

2783

0.75

4.07

1.3

—

Otitis externa

476

5716

0.82

4.06

1.5

1.4

—

Use of donepezil

784

0.55

4.06

1.4

1.5

—

Cholangitis (primary sclerosing, PSC)

1076

0.60

4.05

1.3

1.5

—

Malignant neoplasm of urinary organs

1141

0.62

4.05

1.8

1.5

—

Other fall from one level to another

493

5895

0.83

4.04

1.4

—

Other neurotic disorders

961

0.58

4.04

1.3

1.4

—

Enterocolitis due to Clostridium difficile

101

1503

0.66

4.04

1.5

1.4

—

Other maltreatment syndromes

1052

0.60

4.04

1.3

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

530

0.44

4.02

1.7

1.4

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

223

2894

0.75

4.02

1.4

—

Type of accident

680

7918

0.85

4.02

1.3

1.4

—

Event of undetermined intent

129

1822

0.69

4.01

1.4

—

Other/unspecified enthesopathies, not elsewhere classified

133

1874

0.70

4.01

1.4

—

Crohn disease (strict definition, require KELA)

134

1879

0.70

4.00

1.2

1.4

—

Alcohol abuse counselling and surveillance

467

0.41

3.99

1.4

—

Other local infections of skin and subcutaneous tissue

168

2277

0.73

3.98

1.5

1.4

—

Disorders of muscles

201

2652

0.75

3.98

1.4

—

Use of rivastigmine

573

0.47

3.97

1.5

—

Other disorders involving the immune mechanism, not elsewhere classified

723

0.52

3.95

1.4

—

Dementia in other diseases classified elsewhere

417

0.38

3.95

1.3

1.5

—

Alzheimer’s disease (Late onset)

575

0.51

3.95

1.3

1.5

—

Other pulmonary heart/vessel disease

444

0.40

3.92

1.2

1.4

—

Testicular dysfunction, other/unspecified

109

2.53

3.92

1.6

1.3

—

Acidosis

323

0.30

3.92

1.2

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

641

5152

0.85

3.92

1.5

—

Chronic gastritis

333

4132

0.80

3.89

1.5

—

D07AA Corticosteroids, weak (group I)

375

4575

0.81

3.89

1.3

—

Focal brain injury

1462

0.67

3.89

1.3

1.4

—

Maternal care for other conditions predominantly related to pregnancy

754

8502

0.86

3.88

1.4

1.3

—

Coeliac disease

225

2915

0.76

3.88

1.3

1.4

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

328

4064

0.80

3.88

1.4

—

Visual impairment including blindness (binocular or monocular)

966

0.59

3.88

1.3

1.4

—

Crohn disease (strict definition, require KELA, min 2 HDR)

133

1856

0.70

3.88

1.2

1.4

—

Primary adrenocortical insufficiency

237

0.28

3.87

1.6

1.4

—

Chronic nephritic syndrome

759

0.54

3.87

1.7

1.4

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1261

0.64

3.86

1.8

1.5

—

Cough

986

10558

0.88

3.84

1.4

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

524

0.45

3.84

1.3

1.5

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

237

0.29

3.81

2.0

1.5

—

Amiodarone users

1135

0.63

3.80

1.6

1.5

—

Intestinal adhesions without obstruction

1315

0.65

3.80

1.3

1.5

—

Speech therapy

448

5377

0.83

3.80

1.4

—

Wegener granulomatosis

271

0.32

3.78

1.0

1.4

—

Cystic kidney disease

701

0.53

3.78

1.4

—

Sleep disorders (combined)

4186

20638

1.07

3.78

1.4

—

Vitamin B12 deficiency anaemia

1230

0.64

3.77

1.5

—

Personal history of other diseases and conditions

283

3530

0.79

3.76

1.3

—

Pustular psoriasis

978

0.60

3.76

1.5

1.4

—

Hypercalcemia

571

0.48

3.76

1.5

1.4

—

Faecal incontinence

106

1537

0.68

3.75

1.3

1.4

—

Need for immunization against other single viral diseases

429

0.40

3.75

1.1

1.4

—

Other and unspecified local infections of skin and subcutaneous tissue

155

2105

0.73

3.75

1.5

1.4

—

Cervicalgia

448

5365

0.83

3.74

1.5

1.4

—

Abdominal aortic aneurysm (AAA)

502

0.45

3.74

1.5

—

Other specified/unspecified systemic involvement of connective tissue

1245

0.65

3.74

1.6

1.4

—

Acute sinusitis

1778

18007

0.91

3.73

1.4

—

Accidents

3012

16214

0.93

3.73

1.4

—

Desensitization to allergens

239

1866

1.31

3.71

1.3

—

Other and unspecified effects of external causes

780

8929

0.87

3.71

1.4

—

Generalized epilepsy

1153

0.64

3.67

1.3

—

Iron deficiency

117

820

1.48

3.67

1.4

1.3

—

Polymorphous light eruption

214

0.27

3.67

1.3

1.4

—

Paralytic ileus

539

0.47

3.67

1.1

1.4

—

Haemorrhage, not elsewhere classified

512

0.46

3.66

1.3

1.4

—

Granulomatous disorders of skin and subcutaneous tissue

601

0.50

3.66

1.4

—

Certain disorders involving the immune mechanism

380

4609

0.82

3.66

1.4

—

Conjunctivitis (acute, non atopic)

715

8195

0.86

3.64

1.4

—

Testicular dysfunction

148

1082

1.41

3.64

1.6

1.4

—

Alzheimer’s disease (Early onset), excluding more controls

405

0.41

3.64

1.5

1.4

—

Fibroblastic disorders

391

4732

0.82

3.64

1.4

1.5

—

Malignant neoplasm of kidney, except renal pelvis

1073

0.63

3.63

1.8

1.5

—

Secondary right heart disease

400

0.39

3.63

1.2

1.4

—

Third [oculomotor] nerve palsy

266

0.33

3.63

1.4

—

Adenomyosis (Endometriosis of uterus)

336

2726

1.25

3.62

1.4

1.3

—

Infection of intervertebral disc (pyogenic)

196

0.25

3.62

1.4

—

Non-Hodgkin lymphoma, all

385

0.38

3.61

1.5

1.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

284

3542

0.79

3.61

1.4

—

Ulcerative ileocolitis

1170

0.64

3.60

1.2

1.4

—

Endometriosis diagnosis and infertility diagnosis occurring together

439

3674

1.21

3.58

1.3

—

Lichen simplex chronicus and prurigo

1222

0.65

3.57

1.5

1.4

—

Collagenous colitis

130

1800

0.71

3.57

1.5

1.4

—

6-mercaptopurine

1046

0.62

3.57

1.3

1.4

—

Otalgia

124

1727

0.71

3.55

1.3

1.4

—

Malignant neoplasm of colon

120

1687

0.71

3.55

1.4

1.5

—

Abnormal findings on antenatal screening of mother

276

3434

0.79

3.55

1.3

—

Pustulosis palmaris et plantaris

913

0.60

3.54

1.5

1.4

—

Panniculitis affecting regions of neck and back

863

0.59

3.54

1.4

—

Disorders of tooth development and eruption

560

5296

0.85

3.53

1.3

—

Panhypopituitarism

333

0.35

3.53

1.3

1.4

—

Other shoulder lesions

210

2704

0.77

3.53

1.4

—

Aggressive periodontitis

390

0.40

3.51

1.5

—

Other embolism and thrombosis

185

2425

0.76

3.50

1.3

1.4

—

Other or ill-defined heart diseases

1203

0.65

3.50

1.3

1.4

—

Cystic kidney disease

644

0.53

3.49

1.4

—

Serous carcinoma of ovary, including Hilmo

460

0.45

3.48

1.5

—

Chromosomal abnormalities, not elsewhere classified

561

0.50

3.48

1.4

1.3

—

Superficial injury of ankle and foot

299

3686

0.80

3.46

1.3

1.4

—

Other external causes of accidental injury

3022

16214

0.93

3.44

1.3

1.4

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

157

2097

0.74

3.44

1.5

—

Other disorders of nervous system

1235

0.66

3.43

1.4

1.5

—

Colon adenocarcinoma

1156

0.65

3.43

1.4

1.5

—

Other necrotizing vasculopathies (FG)

847

0.59

3.43

1.3

1.4

—

Gender identity disorders

410

0.42

3.42

1.3

1.2

—

Otitis externa, unspecified

225

2861

0.78

3.41

1.5

1.4

—

Other obstetric conditions, not elsewhere classified

1368

9601

0.90

3.41

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

135

1847

0.72

3.41

1.5

—

Other diseases of pericardium

731

0.56

3.40

1.4

1.5

—

Malignant neoplasm of rectum

1200

0.66

3.40

1.5

—

Internal derangement of knee

1096

12160

0.89

3.40

1.4

—

Other juvenile arthritis

1227

0.66

3.40

1.4

1.3

—

Cerebral palsy

464

0.46

3.40

1.3

—

Fracture at wrist and hand level

1016

11348

0.89

3.40

1.4

—

Other disorders starting during childhood or adolescence

101

1427

0.69

3.39

1.3

1.2

—

Other specified/unspecified inflammatory spondylopathies

108

1520

0.69

3.39

1.3

1.4

—

Drug-induced osteoporosis with pathological fracture

226

0.30

3.38

1.3

1.4

—

Residual foreign body in soft tissue

1416

0.69

3.38

1.6

1.4

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

223

0.31

3.37

1.6

1.5

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

674

0.55

3.37

1.4

—

Nephrotic syndrome

598

0.52

3.36

1.7

1.4

—

Intentional self-harm by unspecified means

392

0.41

3.35

1.2

1.3

—

Exclusion endpoint for clefts

475

0.47

3.34

1.3

—

Radial styloid tenosynovitis [de Quervain]

127

1737

0.72

3.34

1.5

1.4

—

Toxic effect of other and unspecified substances

377

0.41

3.33

1.5

1.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

129

1728

0.72

3.32

1.3

—

Other disorders of kidney and ureter

163

2157

0.75

3.32

1.7

1.5

—

Viral and other specified intestinal infections

654

7333

0.86

3.32

1.3

—

Ulcer of oesophagus

913

0.62

3.30

1.5

—

IgA nephropathy (IgA glomerulonephritis)

566

0.51

3.30

1.5

1.4

—

Thrombocytopenia, unspecified

1213

0.67

3.29

1.6

1.4

—

Cardiac murmurs and other cardiac sounds

181

2328

0.76

3.29

1.3

—

Statin medication

2678

16151

0.93

3.29

1.7

1.3

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1338

9365

0.90

3.29

1.3

—

Use of pramipexole

307

3762

0.81

3.28

1.6

1.5

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

337

0.38

3.27

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

356

4156

0.82

3.27

1.4

—

Other acute viral hepatitis

373

0.41

3.26

1.4

—

Myeloproliferative diseases (CML excluded)

1019

0.64

3.25

1.6

1.5

—

Inflammatory diseases of the central nervous system

146

1951

0.74

3.25

1.3

1.4

—

Cerebral cysts

1394

0.69

3.24

1.4

—

Hypertensive Renal Disease

379

0.42

3.23

1.8

1.4

—

Mixed hyperlipidaemia

681

0.56

3.23

2.1

1.5

—

Other lack of coordination

289

0.34

3.22

1.4

—

Symptoms and signs involving appearance and behaviour

183

0.26

3.22

1.0

1.4

—

Vitamin D deficiency

481

0.48

3.21

1.6

1.4

—

Pregnancy hypertension

1369

13468

0.90

3.21

1.3

1.4

—

Benign paroxysmal vertigo

473

5558

0.85

3.20

1.4

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1207

0.67

3.19

1.4

1.5

—

Disorders of vestibular function (Vertigo)

865

9581

0.88

3.18

1.4

—

Normal-pressure hydrocephalus

250

0.36

3.18

1.2

1.5

—

Viral and other specified intestinal infections

929

10035

0.89

3.17

1.3

—

Motor neuron disease (with DMD)

302

0.36

3.16

1.5

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1062

9541

1.12

3.16

1.5

1.4

—

Total colectomy operation

994

0.64

3.16

1.2

1.4

—

Total colectomy

994

0.64

3.16

1.2

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

1190

0.67

3.15

1.4

—

Other noninflammatory disorders of uterus, except cervix

331

2707

0.82

3.13

1.5

1.4

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1759

15728

1.09

3.13

1.5

1.4

—

Brain glioblastoma and astrocytoma

368

0.42

3.11

1.4

1.5

—

Anxious personality disorder

641

0.56

3.10

1.2

1.3

—

L01XX Other antineoplastic agents

585

0.54

3.09

1.8

1.5

—

Parkinson's disease, including avohilmo

1354

0.70

3.08

1.4

1.5

—

Other and unspecified hydrocephalus

283

0.34

3.08

1.4

—

Cramp and spasm

1049

0.65

3.08

1.6

1.4

—

Unspecified event, undetermined intent

642

0.56

3.07

1.3

1.4

—

Vasculitis limited to skin, not elsewhere classified

436

0.47

3.06

1.3

1.4

—

Myeloproliferative diseases

1160

0.67

3.06

1.5

—

Ankylosing spondylitis, ICD10

187

2393

0.77

3.06

1.3

1.4

—

Dermatophytosis

2016

18663

1.08

3.05

1.4

—

Interstitial lung disease

123

1675

0.73

3.04

1.7

1.5

—

Other interstitial pulmonary diseases

123

1675

0.73

3.04

1.7

1.5

—

Interstitial lung disease endpoints

123

1675

0.73

3.04

1.7

1.5

—

Synovial cyst of popliteal space [Baker]

1357

0.70

3.04

1.3

1.5

—

Inguinal hernia

1654

12036

0.91

3.04

1.4

—

Prurigo nodularis

394

0.45

3.04

1.8

1.4

—

Contact with and exposure to communicable diseases

1137

12499

0.90

3.04

1.3

—

Factors influencing health status and contact with health services

1196

6643

0.90

3.03

1.4

—

Isolated proteinuria with specified morphological lesion

209

0.32

3.02

1.1

1.4

—

Childhood asthma (age<16), excluding more controls

577

5226

0.86

3.02

1.2

—

Diffuse brain injury

948

0.64

3.02

1.7

1.4

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

1157

0.68

3.02

1.5

—

Simple and mucopurulent chronic bronchitis

489

0.50

3.02

1.5

1.4

—

Vascular syndromes of brain in cerebrovascular disorders

436

0.48

3.02

1.5

—

Follicular cysts of skin and subcutaneous tissue

390

4624

0.84

3.01

1.5

1.4

—

Open wound of lower leg

281

3436

0.81

3.01

1.3

1.4

—

Unspecified/other endometriosis

371

3113

1.21

3.00

1.3

—

Juvenile rheumatoid arthirtis

722

0.59

2.99

1.3

1.4

—

Accidental poisoning by and exposure to alcohol

469

0.50

2.99

1.1

1.3

—

Degeneration of macula and posterior pole

436

4089

0.85

2.99

1.6

1.5

—

ILD, hospital admissions

123

1669

0.73

2.98

1.7

1.5

—

Congenital iodine-deficiency syndrome/hypothyroidism

484

0.51

2.97

1.5

1.4

—

Tuberculosis, wide

680

0.58

2.97

1.4

1.5

—

Diseases of the respiratory system

2321

12497

0.93

2.96

1.4

—

Open wound of ankle and foot

206

2597

0.78

2.96

1.4

—

Polyp of the female genital tract

927

4749

1.13

2.95

1.5

1.3

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

132

1761

0.74

2.94

1.4

—

Paraplegia, diplegia of upper limbs

388

0.45

2.94

1.2

1.4

—

Problems related to social environment

559

0.54

2.93

1.5

1.4

—

Contusion of other and unspecified parts of foot

109

1492

0.72

2.93

1.2

1.4

—

Essential (haemorrhagic) thrombocythaemia

560

0.54

2.92

1.3

1.5

—

Traumatic subarachnoid haemorrhage

611

0.56

2.92

1.2

1.4

—

Disorder of the sleep-wake schedule

452

0.49

2.92

1.5

1.3

—

Tuberculosis, IBD comorbidity

677

0.59

2.92

1.4

1.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

488

5665

0.85

2.92

1.4

—

Parkinson's disease

1304

0.70

2.92

1.4

1.5

—

Pre-eclampsia or eclampsia

616

7027

0.87

2.91

1.3

1.4

—

Childhood asthma (age<16)

577

5212

0.86

2.90

1.2

—

Clear cell adenocarcinoma of kidney

610

0.56

2.90

1.7

1.5

—

Disseminated intravascular coagulation [defibrination syndrome]

0.00

2.90

0.0

1.5

—

Other prurigo

203

0.33

2.88

1.3

—

Pruritus

191

2422

0.78

2.88

1.5

1.4

—

Diseases of external ear

713

8064

0.88

2.88

1.5

1.4

—

Nail disorders

156

2026

0.76

2.88

1.3

1.4

—

Other and unspecified neuropathies

0.00

2.87

0.0

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

386

4421

0.84

2.86

1.4

—

Dermatophytosis

201

2532

0.79

2.86

1.4

1.5

—

Other and unspecified vasculitis limited to skin

397

0.47

2.85

1.3

1.4

—

Gestational [pregnancy-induced] hypertension

852

9492

0.89

2.85

1.3

—

Pre-eclampsia

588

6715

0.87

2.84

1.3

1.4

—

Other specified congenital malformation syndromes affecting multiple systems

393

0.47

2.83

1.3

—

Asthma mixed form (mode), excluding more controls

1219

0.69

2.82

1.4

—

Disorders of oesophagus in diseases classified elsewhere

271

0.36

2.82

1.2

1.4

—

Right hemicolectomy

631

0.58

2.81

1.3

1.5

—

Other and unspecified epidermal thickening

538

0.54

2.81

1.6

1.4

—

Malnutrition

270

0.36

2.80

1.2

1.3

—

Visual field defects

103

1417

0.72

2.80

1.5

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2750

19203

0.94

2.79

1.4

—

Inguinal or femoral hernia, bilateral

192

1510

1.28

2.79

1.6

1.5

—

Other demyelinating diseases of the central nervous system

1141

0.68

2.79

1.5

1.4

—

Pneumonia derived septicemia

626

0.58

2.78

1.2

1.4

—

Basal cell carcinoma, including avohilmo

675

5280

0.88

2.78

1.5

—

Pseudomembranous colitis

171

0.28

2.77

1.2

1.4

—

Palindromic rheumatism

214

0.36

2.76

1.1

1.5

—

Ingrowing nail

101

1385

0.72

2.75

1.3

1.4

—

Hypothyroidism due to medicaments and other exogenous substances

215

0.36

2.75

1.6

1.5

—

Neoplasms

3289

18452

0.94

2.74

1.4

1.3

—

Arterial embolism and thrombosis of lower extremity artery

311

0.41

2.74

1.5

1.4

—

Ulcerative enterocolitis

829

0.64

2.74

1.3

1.4

—

Ulcerative rectosigmoiditis

182

2300

0.78

2.73

1.4

—

Examination and encounter for administrative purposes

928

0.66

2.73

1.3

1.4

—

Pneumocystosis

232

0.38

2.72

1.3

1.5

—

Lesion of lateral popliteal nerve

1045

0.68

2.72

1.3

1.4

—

Endocarditis

547

0.56

2.72

1.5

—

Monoamine oxidase A inhibitors

227

2801

0.80

2.71

1.4

—

Osteonecrosis due to drugs

187

0.31

2.71

1.3

1.4

—

Lichen planus

180

2281

0.78

2.71

1.6

1.5

—

Idiopathic pulmonary fibrosis

587

0.57

2.70

1.7

1.5

—

Malignant neoplasm of ovary, including Hilmo

1034

0.68

2.70

1.5

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

862

0.65

2.70

1.4

1.3

—

Disorders of sclera, cornea, iris and ciliary body

1520

16480

0.92

2.70

1.4

—

Asthma mixed form (mode)

1208

0.70

2.70

1.4

—

Unspecified chronic bronchitis

469

0.53

2.69

1.6

1.5

—

Abscess of lung

263

0.37

2.68

1.1

1.4

—

Systemic sclerosis (FG)

491

0.54

2.68

1.3

1.4

—

ILD, hospital admissions 1, main diag only

110

1489

0.73

2.67

1.7

1.5

—

Malignant neoplasm of head and neck

1115

0.69

2.67

1.3

1.5

—

Excessive attrition of teeth

1793

19300

0.92

2.67

1.4

—

Other strabismus

567

6440

0.87

2.67

1.3

1.4

—

Artificial opening status

852

0.65

2.66

1.4

1.5

—

Inguinal hernia, bilateral

188

1486

1.28

2.65

1.6

1.5

—

Superficial injury of lower leg

611

6931

0.88

2.64

1.4

—

Congenital malformations and deformations of the musculoskeletal system

203

2508

0.79

2.63

1.4

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

2076

21150

0.93

2.63

1.4

—

Acute bronchiolitis

1199

0.72

2.62

1.1

1.2

—

Diseases of spleen

316

0.43

2.62

1.2

1.4

—

Other/unspecified synovitis and tenosynovitis

248

3019

0.81

2.62

1.5

1.4

—

Other otitis externa (chronic)

101

1375

0.72

2.62

1.6

1.4

—

Malignant neoplasm of rectum, including Hilmo

120

1597

0.75

2.62

1.5

—

Maternal care for other known or suspected fetal problems

993

6939

0.90

2.61

1.3

—

Discitis, unspecified

227

0.39

2.60

1.4

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1484

13975

0.92

2.60

1.3

1.4

—

Enteropathic arthropathies

635

0.60

2.60

1.2

1.4

—

Malignant neoplasm of eye and adnexa, including Hilmo

209

0.37

2.59

1.8

1.4

—

Open wound of forearm

181

2275

0.79

2.59

1.5

1.4

—

Fracture of skull and facial bones

565

6428

0.87

2.59

1.4

—

Benign neoplasm of other and unspecified endocrine glands

217

2675

0.80

2.58

1.5

1.4

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

737

0.63

2.58

1.4

1.5

—

Premature rupture of membranes

826

6575

0.89

2.57

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

181

0.33

2.56

2.5

1.4

—

Testicular hypofunction

125

947

1.36

2.56

1.6

1.4

—

Visual disturbances and blindness

1176

12853

0.91

2.55

1.4

—

Other acute skin changes due to ultraviolet radiation

586

0.59

2.55

1.5

1.4

—

Other specified/unspecified spondylopathies

314

0.44

2.55

1.5

1.4

—

Endometriosis of intestine

523

1.49

2.55

1.5

1.3

—

Chronic sinusitis

1426

13137

1.09

2.54

1.4

—

Carrier of infectious disease

558

0.58

2.54

1.4

1.3

—

Type 1 diabetes, strict definition, subgroup 2

0.00

2.54

0.0

1.3

—

Malignant neoplasm of small intestine

285

0.41

2.54

1.6

1.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

351

0.47

2.53

1.4

1.3

—

Systemic sclerosis

482

0.55

2.53

1.3

1.4

—

253

0.38

2.53

1.5

1.4

—

Coagulation defects, purpura and other haemorrhagic conditions

378

4420

0.85

2.53

1.4

—

Eating disorders

294

3499

0.83

2.52

1.3

—

Etanercept

140

1805

0.76

2.52

1.4

—

Hypertension, portal

0.00

2.52

0.0

1.5

—

Purpura and other haemorrhagic conditions

222

2722

0.81

2.51

1.5

1.4

—

Excessive vomiting in pregnancy

227

2767

0.81

2.50

1.4

1.3

—

Pervasive developmental disorders excl. Autism + Asperger

278

0.41

2.50

1.5

1.3

—

Phakomatoses, not elsewhere classified

280

0.41

2.50

1.5

1.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

256

0.39

2.50

1.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

619

0.60

2.50

1.8

1.4

—

Respiratory disorders in diseases classified elsewhere

223

0.39

2.49

1.8

1.4

—

Hypothyroidism, other/unspecified

2680

18697

0.94

2.49

1.4

—

Immunodeficiency with predominantly antibody defects

604

0.60

2.49

1.5

1.4

—

Atopic dermatitis, strict definition with reimbursement

1087

11485

0.91

2.48

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1410

15133

0.92

2.48

1.4

—

Eating disorder

255

3066

0.82

2.48

1.3

—

Frostbite

251

0.38

2.47

1.0

1.4

—

Other and unspecified nail disorders

478

0.55

2.47

1.5

1.4

—

Rare circulating lymphoid malignancy, including Hilmo

390

0.50

2.47

1.5

1.4

—

Sixth [abducent] nerve palsy

493

0.56

2.47

1.2

1.4

—

Basal cell carcinoma

614

4811

0.88

2.47

1.5

—

Hypothermia

281

0.42

2.47

1.5

1.4

—

Other symptoms and signs involving the digestive system and abdomen

343

4032

0.84

2.46

1.4

—

Background retinopathy and retinal vascular changes

321

0.46

2.44

1.2

1.4

—

Aphakia

190

0.36

2.44

1.6

1.4

—

Benign neoplasm: Colon, unspecified

297

3536

0.84

2.44

1.6

1.5

—

0.00

2.44

0.0

1.5

—

ILD-related respiratory insufficiency

281

0.42

2.44

1.8

1.5

—

Other diseases of anus and rectum

540

6127

0.88

2.43

1.5

1.4

—

Other and unspecified glaucoma

618

0.61

2.43

1.4

—

Acute posthaemorrhagic anaemia

401

0.52

2.42

1.3

1.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

379

4407

0.85

2.41

1.3

1.4

—

Crohn's disease of small intestine

155

1962

0.78

2.41

1.2

1.4

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cholesterol non HDL [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS